Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
991 Cards in this Set
- Front
- Back
Cause NO release -> vasodilation (veins >>> arteries); used in angina; fast tolerance
|
hypotension, flushing, headache,Nitrates (mechanism, use, toxicity)
|
|
Hepatoxicity and muscle breakdown
|
Adverse effects of statins
|
|
Inhibits lipolysis and reduces VLDL secretion
|
lowering LDL and raising HDL; hyperlipidemia; flushing and hyperuricemia,Niacin (mechanism, use, toxicity)
|
|
Inhibits reabsorption of bile acids -> lower LDL with slight increase in HDL; unpigmented gallbladder stones and malabsorption
|
Cholestyramine, colestipol, colesevelam (mechanism, use, toxicity)
|
|
Prevents cholesterol reabsorption -> lower LDL
|
Ezetimibe
|
|
Upregulates LPL -> lower triglycerides
|
slightly inc. HDL and slightly dec. LDL; myositis and hepatoxicity,Fibrates (gemfibrozil + -fibrates) (mechanism, use, toxicity)
|
|
Inhibits Na/K ATPase -> indirectly inhibits Na/Ca exchanger -> inc. calcium levels -> inc. contractility; stimulates the vagus; causes cholinergic symptoms and hyperkalemia
|
Digoxin and digitoxin (mechanism, use, toxicity)
|
|
Quinidine
|
procainamide, and disopyramide; inc. AP duration and QT interval; can cause torsades de pointes, cinchonism (qunidine), procainamide (drug-induced lupus),Class 1A antiarrhythmics
|
|
Lidocaine
|
mexiletine, and tocainide; dec. AP duration especially in depolarized/ischemia tissue; best following MI,Class 1B antiarrhythmics
|
|
Flecainide
|
propafenone; no effect on AP, used in ventricular tachycardias; do not use post-MI due to risk for arrhythmias,Class 1C antiarrhythmics
|
|
Blocks Na channels
|
decreasing the slope of phase 0 depolarization; toxicity exacerbated by hyperkalemia,Class 1 antiarrhythmics (general mechanism and toxicity)
|
|
Beta-blockers; reduces cAMP
|
slowing SA and AV node activity, increases PR interval; adverse effects include impotence, asthma exacerbation, sedation,Class 2 antiarrhythmics
|
|
Amiodarone
|
ibutilide, dofetilide, sotalol; K channel blockers; inc. AP duration and QT interval,Class 3 antiarrhythmics
|
|
Pulmonary fibrosis
|
hepatotoxicity, thyroid dysfunction,Toxicity of amiodarone
|
|
Ca channel blockers; verapamil and diltiazem; dec. conduction velocity and inc. PR interval; cause constipation
|
flushing, and edema,Class 4 antiarrhythmics
|
|
Inc. K efflux
|
hyperpolarizing the cell; used in supraventricular tachycardias; can cause flushing, hypotension, and chest pain,Adeosine (mechanism, use, toxicity)
|
|
Used in torsades de pointes and digoxin toxicity
|
Magnseium (mechanism, use, toxicity)
|
|
Bromocriptine or cabergoline (dopamine agonists)
|
Treatment for prolactinoma
|
|
Spironolactone (or other AT2 antagonist)
|
Treatment of secondary hyperaldosteronism
|
|
Octreotide (somatostatin analogues)
|
Treatment of carcinoid syndrome
|
|
Lispro
|
aspart, and glulisine,Rapid-acting insulins (3)
|
|
Regular
|
Short-acting insulin (1)
|
|
NPH
|
Intermediate-acting insulin (1)
|
|
Glargine and detemir
|
Long-acting insulins (2)
|
|
Biguanide; unknown mechanism; increases insulin sensitivity and glycolysis and decreases gluconeogenesis; can cause lactic acidosis (don't use in renal failure patients)
|
Metformin (mechanism, use, toxicity)
|
|
First-generation sulfonylureas; close beta-cell K channels
|
causing depolarization and increased insulin release; causes disulfuram-like effects,Tolbutamide, chlorpropamide (mechanism, use, toxicity)
|
|
Second-generation sulfonylureas; close beta-cell K channels
|
causing depolarization and increased insulin release; causes hypoglycemia,Glyburide, glimepiride, glipizide (mechanism, use, toxicity)
|
|
Thiazolidinediones; activates PPAR-gamma
|
increasing insulin sensitivity and adiponectin levels; causes weight gain, hepatotoxicity, and heart failure,Pioglitazone, rosiglitazone (mechanism, use, toxicity)
|
|
Alpha-glucosidase inhibitors; prevent sugar hydrolysis and absorption
|
reducing blood sugar levels,Acarbose, miglitol (mechanism, use, toxicity)
|
|
Amylin analog; reduces glucagon secretion; causes hypoglycemia
|
Pramlintide (mechanism, use, toxicity)
|
|
GLP-1 analogues; increase insulin
|
decrease glucagon secretion; causes pancreatitis,Exenatide, liraglutide (mechanism, use, toxicity)
|
|
DPP-4 inhibitors; increase insulin
|
decrease glucagon secretion; causes mild urinary/respiratory infections,Linagliptin, saxagliptin, sitagliptin (mechanism, use, toxicity)
|
|
Blocks thyroid peroxidase and 5'-deiodinase; used to treat hyperthyroidism; causes agranulocytosis
|
aplastic anemia, hepatotoxicity,Propylthiouracil (mechanism, use, toxicity)
|
|
Blocks thyroid peroxidase; used to treat hyperthyrodism; teratogenic
|
Methimazole (mechanism, use, toxicity)
|
|
Thyroid hormone analogs; causes thyrotoxicosis
|
Levothyroxine, triiodothyronine (mechanism, use, toxicity)
|
|
Used to control uterine hemhorrage
|
Oxytocin (mechanism, use, toxicity)
|
|
ADH antagonist used to treat SIADH; can cause photosensitivty and bone/teeth abnormalities
|
Demeclocycline (mechanism, use, toxicity)
|
|
Inhibits phospholipase A2 activity and expression of COX-2; used for immune suppression; can cause Cushing's syndrome
|
adrenal insufficiency (if withdrawn quickly),Glucocorticoids (mechanism, use, toxicity)
|
|
H2 antagonists; used to treat hyperchloridia; cimeditine is a P-450 inhibitor and has antiandrogenic effects
|
both reduce creatinine secretion,Cimetidine and ranitidine (mechanism, use, toxicity)
|
|
Irreversibly inhibit the H/K pump; used to treat hyperchloridia; increased risk of C. difficile infection and hypomagnesemia
|
-prazoles (mechanism, use, toxicity)
|
|
Coats ulcer base and protects underlying tissue
|
Bismuth, sucralfate (mechanism, use, toxicity)
|
|
PGE1 analog that decreases acid production and increases bicarb production; used to prevent NSAID ulcers; abortifacient (used with Mifepristone (RU-486) Progesterone Blocker
|
Misoprostol (mechanism, use, toxicity)
|
|
Somatostatin analog; used to treat VIPoma and carcinoid syndrome
|
Octreotide (mechanism, use, toxicity)
|
|
Hypokalemia
|
Toxicity of long-term antacid use
|
|
Anti-TNF; used to treat IBD and RA; can cause activation of latent microbes
|
Infliximab (mechanism, use, toxicity)
|
|
Combination of sulfapyridine (antibacterial) and 5-aminosalicylic acid (anti-inflammatory); used to treat IBD; causes oligospermia
|
Sulfasalazine (mechanism, use, toxicity)
|
|
5-HT3 antagonist; used as an antiemetic
|
Ondansetron (mechanism, use, toxicity)
|
|
D2 antagonist; used to increase gut muscle activity and as an antiemetic; causes parkinson signs
|
Metoclopramide (mechanism, use, toxicity)
|
|
Cromolyn sodium
|
Can be used to prevent mast cell degranulation
|
|
Dimercaprol and EDTA
|
succimer in kids,Treatment of lead poisoning
|
|
Activates antithrombin
|
which inactivates thrombin and Xa; used for immediate coagulation and in pregnant women; some patients develop antibodies to platelet factor 4 (HIT),Heparin (mechanism, use, toxicity)
|
|
Same actions as heparin
|
but has a longer half-life, does not have to be monitored as closely, and has a reduced risk of HIT,Enoxaparin, dalteparin (mechanism, use, toxicity)
|
|
Inactivated gamma-carboxylation of factors II
|
VII, IX, X, C, and S; used for long-term and non-immediate anticoagulation; can cause tissue necrosis, teratogenic,Warfarin (mechanism, use, toxicity)
|
|
Converts plasminogen to plasmin; used as a thrombolytic
|
Alteplase, reteplase, tenecteplase (mechanism, use, toxicity)
|
|
Irreversibly inhibits COX-1 and COX-2; anti-platelet and anti-inflammatory; gastric ulcers
|
tinnitus, Reye's syndrome in childhood viral infections,Aspirin (mechanism, use, toxicity)
|
|
Irreversibly blocks ADP receptors on platelets
|
preventing degranulation; used for acure coronary syndrome; ticlodipine causes neutropenia,Clopidogrel, ticlodipine, prasugrel, ticagrelor (mechanism, use, toxicity)
|
|
Phosphodiesterase inhibitor
|
increases cAMP and decreases ADP, preventing platelet degranulation; nausea, headache, facial flushing, hypotension,Cilostazol, dipyridamole (mechanism, use, toxicity)
|
|
GPIIb/IIIa inhibitors
|
preventing platelet aggregation; bleeding, thrombocytopenia,Abciximab, eptifibatide, tirofiban (mechanism, use, toxicity)
|
|
Inhibits dihydrofolate reductase
|
inhibiting DNA synthesis; myelosuppression, macrovesicular fatty change in liver,Methotrexate (mechanism, use, toxicity)
|
|
Pyrimidine analog that is activated and inhibits thymidylate synthase
|
inhibiting DNA synthesis; myelosuppression, photosensitivity,5-fluorouracil (mechanism, use, toxicity)
|
|
Pyrimidine analog that inhibits DNA polymerase; leukopenia
|
thrombocytopenia, megaloblastic anemia,Cytarabine (mechanism, use, toxicity)
|
|
Purine analogs that are activated by HGPRT and inhibit purine synthesis; toxicity is increased with allopurinol
|
causes bone marrow, GI, and liver toxicity,Azathioprine, 6-mercaptopurine, 6-thioguanine (mechanism, use, toxicity)
|
|
DNA intercalator; used for childhood tumors; myelosuppression
|
Dactinomycin (actinomycin D) (mechanism, use, toxicity)
|
|
Generates free radicals that cause DNA strand breaks; dilated cardiomyopathy(Dexrazoxone
|
an iron chelator, prevents this), myelosuppression, alopecia,Doxorubicin (Adriamycin), daunorubicin (mechanism, use, toxicity)
|
|
Generates free radicals that cause DNA strand breaks; pulmonary fibrosis with minimal myelosuppression
|
Bleomycin (mechanism, use, toxicity)
|
|
Crosslinks DNA (must be activated by liver); myelosuppression
|
hemhorragic cystitis (can be minimized with mesna, and N-acetylcysteine (NAC)),Cyclophosphamide, ifosfamide (mechanism, use, toxicity)
|
|
Used to treat CNS tumors
|
Carmustine, lomustine, semustine, streptozocin (mechanism, use, toxicity)
|
|
Alkylates DNA; pulmonary fibrosis
|
hyperpigmentation,Busulfan (mechanism, use, toxicity)
|
|
Block microtubule polymerization; vincristine causes neurotoxicity
|
vinblastine causes bone marro suppression,Vincristine, vinblastine (mechanism, use, toxicity)
|
|
Blocks microtubule breakdown (by hyperstabilization); myelosuppression
|
Paclitaxel (mechanism, use, toxicity)
|
|
Crosslinks DNA; nephrotoxicity (minimize with chloride diuresis
|
amifostine), acoustic n. damage (ototoxicity),Cisplatin, carboplatin (mechanism, use, toxicity)
|
|
Inhibits topoisomerase II; myelosuppression
|
GI upset, alopecia,Etoposide, teniposide (mechanism, use, toxicity)
|
|
Inhibits ribonucleotide reductase and increases HbF; used in cancers and HbSS disease; bone marrow suppression
|
Hydroxyurea (mechanism, use, toxicity)
|
|
Unknown but may trigger apoptosis in dividing cells; Cushingoid symptoms
|
Prednisone (mechanism, use, toxicity)
|
|
Prevents estrogen receptor binding; used in breast cancer and prevention of osteoporosis; tamoxifen increases the risk of endometrial cancer due to agonist effects. Raloxifene = no increase in endometrial cancer.
|
Tamoxifen, raloxifene (mechanism, use, toxicity)
|
|
Antibody against HER-2 receptor; cardiotoxicity
|
Trastuzumab (mechanism, use, toxicity)
|
|
Antibody against bcr-abl tyrosine kinase
|
Imatinib (mechanism, use, toxicity)
|
|
Antibody against CD20; used to treat non-Hodgkin's lymphoma and rheumatoid arthritis
|
Rituximab (mechanism, use, toxicity)
|
|
B-raf kinase inhibitor (V600E mutation); used in metastatic melanoma; B-RAF =proto-oncogene
|
Vemurafenib (mechanism, use, toxicity)
|
|
Antibody against VEGF (used Colon cancer
|
Wet AMD),Bevacizumab (mechanism, use, toxicity)
|
|
Reversible COX inhibitor; gastric ulcers
|
renal ischemia (due to constriction of afferent arteriole),Ibuprofen, naproxen, indomethacin, ketorolac, diclofenac (mechanism, use, toxicity)
|
|
Reversible COX-2 inhibitor; anti-inflammatory without damage to gastric mucosa; sulfa allergy
|
thrombosis,Celecoxib (mechanism, use, toxicity)
|
|
COX inhibitor in the CNS (not anti-inflammatory); causes hepatic necrosis
|
Acetominophen (mechanism, use, toxicity)
|
|
Pyrophosphate analog that inhibits osteoclasts; used to treat osteoporosis
|
hypercalcemia, and Paget's disease; corrosive esophagitis,Alendronate (mechanism, use, toxicity)
|
|
Xanthine oxidase inhibitor
|
reduces production of uric acid,Allopurinol (mechanism, use, toxicity)
|
|
Xanthine oxidase inhibitor
|
Febuxostat (mechanism, use, toxicity)
|
|
Inhibits reabsorption of uric acid in PCT
|
Probenecid (mechanism, use, toxicity)
|
|
Inhibits microtubule polymerization
|
preventing neutrophil extravasation,Colchine (mechanism, use, toxicity)
|
|
TNF-alpha receptor that binds free TNF-alpha; Decoy receptor mimicking inactivating effects of soluble TNF
|
Etanercept (mechanism, use, toxicity)
|
|
Anti-TNF-alpha antibody
|
Infliximab, adalimumab (mechanism, use, toxicity)
|
|
PGF2 analog that increases the outflow of aqueous humor; can cause darkening of the iris
|
Latanoprost (mechanism, use, toxicity)
|
|
Mu opioid agonists that open K channels and close Ca channels
|
inhibting synaptic transmission; addiction, respiratory depression, constipation, miosis,Morphine, fentanyl, cofeine, heroin, methadone, meperidine, dextromethorphan, diphenoxylate (mechanism, use, toxicity)
|
|
Mu opioid partial agonist; used to treat severe pain; causes withdrawal if being treated with full agonist
|
Butorphanol (mechanism, use, toxicity)
|
|
Weak opioid agonist that inhibits serotonin and NE reuptake; increases risk for seizures
|
Tramadol (mechanism, use, toxicity)
|
|
Carbamazepine
|
First-line therapy for simple partial seizures
|
|
Carbamazepine
|
First-line therapy for complex partial seizures
|
|
Carbamazepine
|
phenytoin, valproate,First-line therapies for tonic-clonic seizures (3)
|
|
Ethosuximide
|
First-line therapy for absence seizures
|
|
Increases Na channel inactivation and inhibits glutamate release; used for simple
|
complex, and tonic-clonic seizures and status epilecticus prophylaxis; nystagmus, gingival hyperplasia, hirsutism, megaloblastic anemia, teratogenic, drug-induced lupus, P450 inducer,Phenytoin (mechanism, use, toxicity)
|
|
Increases Na channel inactivation; first-line for simple
|
complex, and tonic-clonic seizures and trigeminal neuralgia; agranulocytosis, aplastic anemia, P450 inducer, SIADH, liver toxicity,Carbamazepine (mechanism, use, toxicity)
|
|
Blocks Na channels; used for simple
|
complex, and tonic-clonic seizures; Steven-Johnson syndrome,Lamotrigine (mechanism, use, toxicity)
|
|
Inhibits Ca channels; used for simple
|
complex, and tonic-clonic seizures, migraine prophylaxis, peripheral neuropathy, bipolar disorder; ataxia,Gabapentin (mechanism, use, toxicity)
|
|
Blocks Na channels and increases GABA secretion; used for simple
|
complex, and tonic-clonic seizures and migraine prevention; mental dulling, kidney stones, weight loss,Topiramate (mechanism, use, toxicity)
|
|
Increases GABA channel action; first-line for simple
|
complex, and tonic-clonic seizures in children; P450 inducer,Phenobarbital (mechanism, use, toxicity)
|
|
Increases Na channel inactivation and increases GABA levels; first-line for tonic-clonic seizures
|
used for simplex, complex, tonic-clonic, and myoclonic seizures; hepatotoxicity, neural tube defects, weight gain, tremor,Valproate (mechanism, use, toxicity)
|
|
Blocks thalamic Ca channels; first-line for absence seizures; GI distress
|
Steven-Johnson syndrome,Ethosuximide (mechanism, use, toxicity)
|
|
Increases frequency of GABA channel opening; first-line for status epilepticus (diazepam
|
lorazepam), used for eclampsia seizures (diazepam, lorazepam), anxiety, alcohol withdrawl, sleep walking, night terrors; sedation,Benzodiazepines (mechanism, use, toxicity)
|
|
Inhibits GABA reuptake; used for simple and complex seizures
|
Tiagabine (mechanism, use, toxicity)
|
|
Irreversibly inhibits GABA transaminase
|
increasing GABA concentration; used for simple and complex seizures,Vigabatrin (mechanism, use, toxicity)
|
|
Unknown mechanism; used for simple
|
complex, and tonic-clonic seizures,Levetriacetam (mechanism, use, toxicity)
|
|
Increase duration of GABA channel opening; induction of anesthesia
|
sedative; CNS depression, P450 inducer, contraindicated in patients with porphyrias,Phenobarbital, pentobarbial, thiopental, secobarbital (mechanism, use, toxicity)
|
|
Short-acting benzodiazepines; more addictive potential
|
Triazolam, oxazepam, midazolam (mechanism, use, toxicity)
|
|
Increase duration vs. increase frequency
|
Barbituates vs. benzodiazepines (mechanism)
|
|
BZ1 subtype GABA channel agonists; used to treat insomnia
|
Zolpidem, zaleplon, eszopiclone (mechanism, use, toxicity)
|
|
Blocks NMDA receptor; used as an anesthetic; increases cardiac activity
|
hallucinations, bad dreams,Ketamine (mechanism, use, toxicity)
|
|
Pain -> temperature -> touch -> pressure
|
Order of sensory loss when using local anesthetics
|
|
ACh receptor agonist
|
produces sustained depolarization and desensitization; used as a paralytic; hypercalcemia, hyperkalemia, malignant hyperthermia,Succinylcholine (mechanism, use, toxicity)
|
|
ACh antagonists; used as paralytics
|
Tubocurarine, -curium drugs (mechanism, use, toxicity)
|
|
Inhibits release of Ca from sarcoplasmic reticulum and skeletal muscle; used to treat malignant hyperthermia and neuroleptic-malignant syndrome
|
Dantrolene (mechanism, use, toxicity)
|
|
Converted to dopamine by dopa decarboxylase in CNS/inhibits peripheral dopa decarboxylase activity; used to treat parkinson symptoms; can cause arrhythmias and "on/off" phenomenon
|
Levodopa/carbidopa (mechanism, use, toxicity)
|
|
MAO-B (prefers dopamine for breakdown) inhibitor
|
inhibits dopamine breakdown; used to treat parkinson symptoms; enhances adverse effects of levodopa,Selegiline (mechanism, use, toxicity)
|
|
ACh esterase inhibitors; used to treat Alzheimer's disease; cholinergic symptoms
|
Donepezil, galantamine, rivastigmine (mechanism, use, toxicity)
|
|
Agonist at 1B/1D serotonin receptors; used to treat acute migraines and cluster headaches; coronary vasospasm
|
Sumatriptan (mechanism, use, toxicity)
|
|
High potency antipsychotics that antagonize D2 receptors; used to treat schizoprehnia
|
psychosis, mania, and Tourette's; hyperprolactinemia, anti-cholinergic symptoms (dry mouth, constipation), extrapyramidal effects (dyskinesia), neuroleptic malignany syndrome, tardive dyskinesia (haloperidol),Trifluoperzine, fluphenazine, haloperidol (mechanism, use, toxicity)
|
|
Low potency antipsychotics that antagonize D2 receptors; used to treat schizophrenia
|
psychosis, mania, and Tourette's; corneal deposits (chlorpromazine), retinal desporits (thioridazine),Chlorpromazine, thioridazine (mechanism, use, toxicity)
|
|
Atypical antipsychotics with unknown mechnism; used for schizophrenia
|
bipolar disorder, OCD, and others; weight gain (olanzapine, clozapine), agranulocytosis (clozapine), seizures (clozapine), prolonged QT (ziprasidone),Olanzapine, clozapine, quetiapine, risperidone, aripripazole, ziprasidone (mechanism, use, toxicity)
|
|
Unknown mechanism; used for bipolar disorder and SIADH; tremor
|
sedation, edema, hypothyroidism, polyuria,Lithium (mechanism, use, toxicity)
|
|
Agonizes 1A serotonin receptors; used for generalized anxiety disorder; no side effects
|
but takes 1-2 weeks for improvement,Buspirone (mechanism, use, toxicity)
|
|
Block reuptake of serotonin from the synaptic cleft; depression and others; sexual dysfunction
|
sertonin syndrome (hyperthermia, myoclonus, flushing, diarrhea, seizures),Fluoxetine, paroxetine, sertraline, citalopram (mechanism, use, toxicity)
|
|
Block reuptake of NE and serotonin from synaptic cleft; depression
|
diabetic neuropathy (duloxetine); hypertension,Venlafaxine, duloxetine (mechanism, use, toxicity)
|
|
TCAs
|
block reuptake of NE and serotonin; depression, bewetting (imipramine), OCD (clomipramine); convulsions, coma, arrhythmias, sedation, hypotension, anti-cholinergic effects,-iptyline, -ipramine, doxepin, amoxapine (mechanism, use, toxicity)
|
|
Inhibit breakdown of NE
|
serotonin, and dopamine; used for atypical depression, anxiety, and hypochondriasis; hypertensive crisis (tyramine in wine/cheese), don't use with other serotonin agonists,Tranylcypromine, phenelzine, isocarboxazid, selegiline (mechanism, use, toxicity)
|
|
Increases NE and dopamine; used for smoking sensation
|
depression; seizures,Bupropion (mechanism, use, toxicity)
|
|
Alpha-2 antagonist
|
increases NE and serotonin release, and serotonin receptor agonist; used for depression; sedation, increased appetite with weight gain;,Mirtazapine (mechanism, use, toxicity)
|
|
Blocks NE reuptake; used for depression; sedation
|
hypotension,Maprotiline (mechanism, use, toxicity)
|
|
Inhibits serotonin uptake; used for insomnia; pripism
|
Trazodone (mechanism, use, toxicity)
|
|
Osmotic diuretic; used to treat drug overdose and increased ICP; pulmonary edema
|
CHF,Mannitol (mechanism, use, toxicity)
|
|
Carbonic anhydrase inhibitor; used for glaucoma
|
metabolic alklalosis; hyperchloremic metabolic acidosis, ammonia toxicity, sulfa allergy,Acetazolamide (mechanism, use, toxicity)
|
|
Inhibits NKCC channel
|
preventing urine concentration; used in hypertension, CHF, hypercalcemia; ototoxicity, hypokalemia, hypocalcemia, nephritis, gout, sulfa allergy; mimics Barter's Disease,Furosemide (mechanism, use, toxicity)
|
|
Inhibits NKCC channel; used in patients with furosemide (sulfa) allergy; hyperuricemia
|
Ethacrynic acid (mechanism, use, toxicity)
|
|
Inhibits NaCl reabsorption in DCT and increases Ca reabsorption; hypertension and hypercalcinuria; hyperglycemia
|
hyperlipidemia, hyperuricemia, hypercalcemia, sulfa allergy; Mimics Gitelman's disease,Hydrochlorothiazide (mechanism, use, toxicity)
|
|
Aldosterone receptor antagonists; hyperaldosteronism
|
CHF, hypokalemia; hyperkalemia (arrhythmias), antiandrogen effects with spironolactone,Spironolactone, eplerenone (mechanism, use, toxicity)
|
|
Block sodium channels in cortical collecting duct; hyperaldosteronism
|
CHF; used to tx Liddle's Dx,Triamterene, amiloride (mechanism, use, toxicity)
|
|
ACE inhibitor
|
leads to reduced angiotensin II levels and decreases GFR; prevents heart remodeling, hypertension, CHF; cough, angioedema, transient creatinine increase, hyperkalemia,Captopril, enalapril, lisinopril (mechanism, use, toxicity)
|
|
Angiotensin II receptor antagonists; similar to ACE inhibitors
|
but do not cause cough due to normal metabolism of bradykinin,Losartan, valsartan (mechanism, use, toxicity)
|
|
GnRH analog that acts as an agonist in pulsatile doses and an antagonist in continuous doses; used as an agonist for infertility and an antagonist for prostate cancer
|
fibroids, and precocious puberty; antiandrogenic,Leuprolide (mechanism, use, toxicity)
|
|
5-alpha reductase inhibitor; used for BPH and male-pattern baldness
|
Finasteride (mechanism, use, toxicity)
|
|
Testosterone receptor antagonist; used in prostate cancer
|
Flutamide (mechanism, use, toxicity)
|
|
Inhibits 17
|
20-desmolase, stopping sex steroid synthesis; used to treat polycystic ovarian syndrome,Ketoconazole (mechanism, use, toxicity)
|
|
Partial estrogen agonist in the hypothalamus
|
increases release of LH and FSH, stimulating ovulation; used for infertility and PCOS,Clomiphene (mechanism, use, toxicity)
|
|
Estrogen receptor antagonist at the breast; used for breast cancer; partial agonist at the uterus
|
can cause endometrial hyperplasia,Tamoxifen (mechanism, use, toxicity)
|
|
Estrogen receptor agonist at bone
|
inhibits osteoclast activity and stimulates osteoblast activity; used to treat osteoporosis,Raloxifene (mechanism, use, toxicity)
|
|
Aromatase inhibitors; used in breast cancer
|
Anastrozole, exemestane (mechanism, use, toxicity)
|
|
Progesterone receptor antagonist
|
given with misoprostol for abortion; abortifacient; bleeding, abdominal pain,Mifepristone (mechanism, use, toxicity)
|
|
Beta-2 agonist
|
inhibits uterine contractions,Terbutaline (mechanism, use, toxicity)
|
|
Alpha-1 antagonist; used to treat BPH
|
Tamsulosin (mechanism, use, toxicity)
|
|
Phosphodiesterase 5 inhibitors
|
causing inc. cGMP levels and smooth muscle relaxation; used in erectile dysfunction; impaired blue-green vision, contradindicated with nitrates,Sildenafil, vardenafil (mechanism, use, toxicity)
|
|
Partial androgen receptor agonist; used to treat endometriosis and hereditary angioedema; weight gain
|
acne, hirsutism, low HDL, hepatoxicity,Danazol (mechanism, use, toxicity)
|
|
Methylene blue
|
Treat methemoglobinemia with
|
|
(First generation) H1 antagonists; used in allergies
|
motion sickness, insomnia; sedation, antiadrenergic, antiserotonergic, and antimuscarinic effects due to CNS penetration,Diphenhydramine, dimenhydrinate, chlorpheniramine (mechanism, use, toxicity)
|
|
H1 antagonists
|
2nd gen; used in allergies; less fatigue than 1st gen antihistamines due to decreased CNS penetration,Loratadine, fexofenadine, desloratadine, cetrizine (mechanism, use, toxicity)
|
|
Short-acting beta-2 agonist; asthma
|
Albuterol (mechanism, use, toxicity)
|
|
Long-acting beta-2 agonist; asthma; tremor
|
arrhythmias,Salmeterol, formoterol (mechanism, use, toxicity)
|
|
Phosphodiesterase inhibitor
|
increases cAMP and causes bronchodilation; asthma; cardiotoxicity, neurotoxicity, Inhibits adenosine (puringeric inhibit AC--> decrease cAMP), proarrythmic (increases cAMP),Theophylline (mechanism, use, toxicity)
|
|
Muscarinic antagonist
|
prevents bronchoconstriction; asthma and COPD,Ipratropium (mechanism, use, toxicity)
|
|
Inhibit cytokine synthesis
|
reducing inflammation due to asthma; 1st line for chronic asthma,Beclomethasone, fluticasone (mechanism, use, toxicity)
|
|
Leukotriene receptor antagonists; especially useful in aspirin-induced asthma
|
Montelukast, zafirlukast (mechanism, use, toxicity)
|
|
Inhibits activity of 5-lipoxygenase
|
inhibiting leukotriene production; reduces inflammation,Zileuton (mechanism, use, toxicity)
|
|
Anti-IgE antibody; used in refractory allergic asthma
|
Omalizumab (mechanism, use, toxicity)
|
|
Thins respiratory secretions
|
Guaifenesin (mechanism, use, toxicity)
|
|
Loosens mucus plugs; used in CF patients and as an antidote to acetominaphen poisoning; also used in cyclophosphmide toxicity of hemorrhagic cystitis
|
N-acetylcysteine (mechanism, use, toxicity)
|
|
Antagonizes endothelin-1 receptors
|
reducing vascular resistance in the pulmonary vessels; used in pulmonary hypertension,Bosentan (mechanism, use, toxicity)
|
|
Antagonizes NMDA receptors
|
inhibiting coughing; produces opioid effects in large doses and carries mild abuse potential,Dextromethorphan (mechanism, use, toxicity)
|
|
Alpha-1 agonists that reduce edema and nasal congestion; rhinitis; hypertension
|
quick tolerance (recurrence of symptoms despite continued treatment),Pseudoephedrine, phenylephrine (mechanism, use, toxicity)
|
|
competitive = decrease potency
|
noncompetitive = decrease efficacy.,Difference in competitive vs noncompetitve inhibitors?
|
|
Inverse relation of affinity of enzyme for its substrate.
|
What is Km?
|
|
Direct proportion to enzyme concentration
|
What is Vmax?
|
|
Fraction of administered drug that reaches systemic circulation unchanged.
|
What is bioavailability?
|
|
depends on half-life. Does not depend on frequency or size of dose.
|
Time to steady state depends on?
|
|
constant amount eliminated per time.
|
What is rate of elimination in zero order kinetics?
|
|
PEA - phenytoin
|
Ethanol, Aspirin.,Give three drugs that are zero order eliminated.
|
|
A constant FRACTION is eliminted
|
variable by concentration!,What is the rate of elimination for first order kinetics?
|
|
Ionzied species are trapped in urine and not resorbed. Neutral can be resorbed.
|
How does ionization relate to urine pH?
|
|
Treat with Bicarb to make neutral. Exp: phenobarbital
|
methotrexate, aspirin.,How do you treat overdose of weak acid? Give drug examples.
|
|
Treat with ammonium chloride. exp: amphetamines.
|
How do you treat overdose of weak base? Give drug examples.
|
|
Reduction
|
Oxidation, hydrolysis with CYP450. Often gives neutral products. Geriatrics lose this phase.,What is phase I drug metabolism? What pt. population loses this?
|
|
Conjugation (Glucuronidation
|
Acetylation, and Sulfation.) Gives charged products. Geriatrics depend on this, old people have GAS.,What is phase II metaboloism? What population depend on this?
|
|
maximal effect a drug can produce.
|
What is efficacy?
|
|
amount of drug needed for the same effect.
|
What is potency?
|
|
DECREASED efficacy. fight for same binding site
|
full agonist cant exert full effect.,What happends to efficacy when a partial agonist and full agonist are mixed?
|
|
LD50/ED50. Median lethal dose divded by median effective dose. Safer drugs have a higher TI.
|
What is therapetuic index?
|
|
Minimum effective dose to minimum toxic dose. Think of it as range of use.
|
What is a therapeutic window?
|
|
1. Nicotinic - Ligang gated Na/K channels. Two nicotinic types: Nm(NMJ) and Nn(autonomic ganglia. 2. Muscarinic - G-proteins. 5 types
|
M1-M5.,What are the two types of Nicotonic receptors? What kind of messenger do they use?
|
|
q
|
increase: vasc. smooth muscle contraction, pupillary dilator muscle contraction, intestinal and bladder sphincter contaction.,Alpha-1 sympathetic receptor (G-protein class, major function)
|
|
i
|
decrease: sympathetic outflow, insulin release, lipolysis. increase: platlet aggregation.,Alpha-2 sympathetic receptor(G-protein class, major function)
|
|
s
|
increase: heart rate, contractilty, renin release, lipolysis,Beta-1 sympathetic receptor(G-protein class, major function)
|
|
s
|
vasodilation, brochodilation, increase: heart rate, contractility, lipolysis, insulin release, aqueous humor production. decrease: uterine tone, ciliary muscle tone.,Beta-2 sympathetic receptor(G-protein class, major function)
|
|
q
|
CNS, enteric nervouse system.,M-1 Parasymp receptor(G-protein class, major function)
|
|
i
|
decease: heart rate, contractility of atria,M-2 Parasymp(G-protein class, major function)
|
|
increase: exocrine gland secretion (tears
|
gastric, etc), gut peristalsis, bladder contraction, bronchoconstriction, pupillary spinchter contraction, cilliary muscle contraction.,M-3 parasymp(G-protein class, major function)
|
|
Parasympathetic M-3.
|
What receptor is responsible for miosis and accomadation?
|
|
Sympathetic Alpha-1.
|
What receptor is responsbile for mydriasis?
|
|
s
|
relaxes renal vascular smooth muscle,Dopamine D-1 receptor(G-protein class, major function)
|
|
i
|
modulates transmitter release especially in brain.,Dopamine D-2 receptor(G-protein class, major function)
|
|
q
|
increase: mucus production, contraction of bronchioles, pruritus, pain.,Histamine H-1 receptor(G-protein class, major function)
|
|
s
|
increase gastric acid secretion,histamine H-2 receptor(G-protein class, major function)
|
|
q
|
increase: vascular smooth muscle contraction,vasopression V-1 receptor(G-protein class, major function)
|
|
s
|
increase water permeability and reabsorption in kidneys. (V2 found in 2 kidneys).,vasopression V-2 receptor(G-protein class, major function)
|
|
H1
|
Alpha1,V1,M1,M3. (remember HAVe 1 M&M),Which receptors work via Gq -> Phospholipase C ->Pip2->DAG + IP3?
|
|
Protein Kinase C.
|
DAG causes activation of what?
|
|
Calcium -> smouth muscle contraction
|
IP3 causes increase in what?
|
|
M2
|
Alpha2, D2. (remember MAD 2's.),Which receptors work via Gi->Adenyly cyclase ->cAMP ->Protein Kinase A?
|
|
Beta1
|
Beta2, D1, H2,V2.,Which receptors work via Gs->adenylyate cyclase ->cAMP->Protein Kinase A?
|
|
increase calcium release in heart and blocks myosin light chain kinase.
|
What does protein kinase C do?
|
|
1. direct agonsts 2. indirect agonists (anticholinesterases).
|
What are the two classes of cholinomimetics?
|
|
Direct cholinomimetic. Postop or neurogenic ileus
|
urinary retention. COPD+asthma exacerbation, peptic ulcers.,Bethanechol(mechanism,use,toxicity)
|
|
Direct Cholinomimetic. Identical to Ach. Glaucoma
|
pupillary contraction, relief of IOP. COPD+asthma exacerbation, peptic ulcers.,Carbachol(mechanism,use,toxicity)
|
|
Direct Cholinomimetic. Stimulates tears
|
salvia, sweat. Open and closed-angle glaucoma.COPD+asthma exacerbation, peptic ulcers.,Pilocarpine(mechanism,use,toxicity)
|
|
Direct Cholinomimetic. challenge test of asthma diagnosis. COPD+asthma exacerbation
|
peptic ulcers.,methacholine(mechanism,use,toxicity)
|
|
Indirect cholinomimetic agonist. NO cns penetration. Postop and neurogenic ileus
|
myasthenia gravis, reversal of NMJ block. COPD+asthma exacerbation, peptic ulcers.,Neostigmine(mechanism,use,toxicity)
|
|
indirect cholinomimetic agonist. Long acting myasthenia gravis treatment. COPD+asthma exacerbation
|
peptic ulcers.,pyridostigmine(mechanism,use,toxicity)
|
|
indirect cholinomimetic agonist. Short acting
|
for myasthenia gravis diagnosis. COPD+asthma exacerbation, peptic ulcers.,edrophonium(mechanism,use,toxicity)
|
|
indirect cholinomimetic agonist. for anti-cholinergic overdose
|
crosses BBB. COPD+asthma exacerbation, peptic ulcers.,Physostigmine(mechanism,use,toxicity)
|
|
indirect cholinomimetic agonist. Alzheimers disease. COPD+asthma exacerbation
|
peptic ulcers.,Donepezil(mechanism,use,toxicity)
|
|
DUMBBELSS (diarrhea
|
urination, miosis, bronchospasm, bradycardia, excitation of skeletal muscle +CNS, lacrimation, sweating, salvia.) tx: atropine + pralidoxime.,signs of cholinesterase inhibitor poisoning. treatment.
|
|
Irreversible cholinesterase inhibitor
|
ACH overdose. Tx: atropine + pralidoxime.,Parathion(mechanism, treatment)
|
|
Muscarinic antagonist. produces mydriasis and cycloplegia. (Atropine also used for bradycardia). Causes hot as a hare
|
dry as bone, red as beet, blind as bat, mad as a hatter.,Atropine, homatropine, tropicamide (mechanism, use, toxicity).
|
|
Muscarinic antagoist. Parkinsons disease (park my benz). Can be used in haloperiodal O.D
|
whihc causes torticolliosis. Causes hot as a hare, dry as bone, red as a beet, blind as a bat, mad as a hatter.,Benztropine(mechanism,use,toxicity)
|
|
Muscarinic antagonist. Motion sickness. causes hot as a hare
|
dry as a cone, red as a beet, blind as a bat, mad as a hatter.,Scopolamine(mechanism,use,toxicity)
|
|
Muscarinic antagonist. COPD
|
Asthma. Causes hot as a hare, dry as a bone, red as a beet, blind as a bat, mad as a hatter.,Ipratropium,tiotropium (mechanism, use, toxicity)
|
|
Muscarinic anatagonist. reduces urgency in mild cystitis and reduce bladder spasms. causes hot as a hare
|
dry as a bone, red as a beet, blind as a bat, mad as a hatter.,Oxybutynin(mechanism,use,toxicity)
|
|
Muscarinic anatagonist. IP: given in preop to reduce airway secretions. oral:reduce drooling
|
peptic ulcer. Can cause hot as a hare, dry as a bone red as a beet, blind as a bat, mad as a hatter.,Glycopyrrolate(mechanism,use,toxicity)
|
|
muscarinic antagonist
|
causes gardner's pupil (mydriasis).,Jimson Weed(mechanism, toxicity)
|
|
Direct Sympathomemetic. A1
|
A2,B1,B2. Anaphylaxis, open angle glaucoma, asthma, hypotension.,Epinephrine(Mechanism, receptors bound, use, toxicity)
|
|
direct sympathomemetic. A1
|
A2, some B1. used in hypotension but it decrease renal perfusion.,Norepinephine(Mechanism, receptors bound, use, toxicity)
|
|
Direct sympathomemetic. B1
|
B2. Used in Torsade de pointe and bradyarryhmia. Can cause tachycardia and worsen cardiac ischemia.,Isoproterenol(Mechanism, receptors bound, use, toxicity)
|
|
Direct sympathomimetics. Receptors depend on dose. low = D1
|
med = D1,B2,B1, high = A1,A2,B1,B2,D1. Used in shock and heart failure (ionotropic and chronotropic).,dopamine(Mechanism, receptors bound, use, toxicity)
|
|
Direct sympathomimetic. Mostly B1
|
little a1,a2,b2. Used in heart failure and cardiac stresstest (ionotrpic and chronotropic),dobutamine(Mechanism, receptors bound, use, toxicity)
|
|
Direct sympathomimetic. A1
|
A2. Used in hypotension, to cause mydriasis, and rhinitis (decongestant).,Phenylephrine(Mechanism, receptors bound, use, toxicity)
|
|
Direct sympathomimetic. Mostly B2
|
some b1. Sal = long term ashtma or copd. Albuterol for short term asthma. Terbutaline for to reduce premture uterine contractions.,Albuterol, salmetrol, terbutaline (Mechanism, receptors bound, use, toxicity)
|
|
Direct sympathomimetic. B2 only. Used to reduce premature uterine contractions.
|
Ritodrine(Mechanism, receptors bound, use, toxicity)
|
|
indirect sympathomimetic. Releases stored catecholamines. Used for narcolepsy
|
obesity, ADD.,Amphetamine (mechanism, use)
|
|
indirect sympathomimetic. Releases stored catecholamines. Used for nasal decongestion
|
urinary incontience, hypotension.,Epinephrine(Mechanism, use, toxicity)
|
|
direct sympathomimetic. Reuptake inhibitor. Causes vasoconstriction and local anesthesia.
|
Cocaine (mechanims, use).
|
|
mixing them can lead to unopposed A1 activation and extreme hypertenion.
|
Why must B-Blockers be avoided in suspected cocaine intoxication?
|
|
stimulates A1>B2. Causes increased vasoconstrciton -> increased BP. This causes reflex bradycardia and slowing of HR.
|
How does norepinephrine cause reflex bradycardia?
|
|
Stimulates B2>A1. This cause vasodilation and dropping of BP. B1 is stimulated and causes tachycardia.
|
How does isoproterenol cause reflex tachycardia?
|
|
Centrally acting alpha-2 agonists
|
this causes LESS peripheral sympathetic release.Used in hypertension, especially renal disease due to no increase in renal blood flow!,Clonidine, alpha-methyldopa(Mechanism, receptors bound, use)
|
|
IRREVERSIBLE nonslective alpha blocker. Used in pheochromosytoma BEFORE surgery! toxic: orhtostatic hypotension
|
reflec tachycardia.,Phenoxybenzamine(Mechanism, receptors bound, use, toxicity)
|
|
REVERSBILE nonselective alpha blocker. give to patients on MAOI who each tyramine contraining foods.
|
phentolamine(Mechanism, receptors bound, use, toxicity)
|
|
Alpha-1 blocker. Used in hypertension
|
urinary rentention in BPH. tox:orthostatic hypotension, dizziness, headache.,Prazosin, Terazosin, Doxazosin,Tamsulosin(Mechanism, receptors bound, use, toxicity)
|
|
Alpha-2 blocker. Used in depression. tox: sedation
|
hypercholesterolemia, increased apetite.,Mirtazapine (mechanism, use, toxicity)
|
|
Before blockade: Both epi and phen RAISES BP. After alpha blockade: only epi raises
|
no change in phenyl. Why: Epi has B binding, phenyl does NOT.,Describe what occurs when you alpha-blockade epi vs. phenylephrine.
|
|
Angina - decreases HR and contractility
|
decreasing oxygen use. MI - decrease mortality. SVT - decrease AV duction. Hypertension - decrease CO and renin secretion. CHF - slows progression. Glaucoma - decrease secretion of aqueous humor.,Give 6 applications of Beta-blockers in general.
|
|
impotence
|
asthma exacerbation, bradycardia, seizures, sedation, hides hypoglycemia.,give general toxicites of b-blockers
|
|
A BEAM. acebutolol
|
betaxolol, Esmolol, Atenolol, Metoprolol. Useful in comorbid pum. disease.,What are the B1 selective b-blockers? When are they useful?
|
|
Please Try Not Being Picky. Propranolol
|
Timolol, Nadolol, Pindolol. B = B-blocker.,What are the nonselective ( b1 = b2) b-blockers?
|
|
Carvedilol
|
labetalol.,what are the nonselective a and b-antagonists?
|
|
Pindolol
|
Acebutolol.,What are the partial B-agonists?
|
|
N-Acetylcysteine (replenishes glutathione).
|
Give treatment for acetaminophen overdose.
|
|
NaHCO3 (alkalinize urine)
|
Give treatment for salicylates overdose.
|
|
NH4Cl (acidify urine)
|
give treatment for amphetamines overdose
|
|
Phygostigmine and control the hyperhermia.
|
Give treatment for antimuscarinic and anticholinergic overdose.
|
|
Glucagon
|
Give treatment for b-blocker overdose
|
|
(KLAM) normalize K
|
Lidocaine, Anti-dig fab fragments, Mg2,Give treatment for digitalis overdose
|
|
deFEroxamine
|
deFErasirox.,give treatment for iron overdose.
|
|
CaEDTA
|
dimercaprol, succimer, penicillamine,give treatment for lead overdose
|
|
Dimercaprol
|
succiner,give treatment for mercury, arsenix, gold overdose
|
|
penillamine
|
give treatment for copper, arsenic, gold overdose
|
|
nitrite + thiosulfate
|
hydroxocobalamin,give treatment for cyanide
|
|
Methylene blue
|
vitamin c,give methemoglobin treatment
|
|
100% oxygen or hyperbaric oxygen
|
Give Carbon monocide treatment
|
|
Fomepizole>Ethanol
|
dialysis,give treatment for methanol, ethylene glycol overdose
|
|
naloxone/naltrexone
|
give treatment for opiods overdose
|
|
flumazenil
|
give treatment for benzodiazepine overdose
|
|
NaHCO3 (alkalinize plasma)
|
give treatment for TCA overdose
|
|
protamine
|
give treatment for heparin overdose
|
|
Vitamin K
|
fresh frozen plasma,give treatment for warfarin overdose
|
|
aminocaproic acid
|
give treatment for tPA, Streptokinase, urokinase overdose
|
|
B-Blockers
|
give treatment for theophylline overdose
|
|
atropine + pralidoxime
|
give treatment for acetylcholinesterase inhibitors
|
|
cocaine
|
sumatriptan, ergots,causes coronary vasospam
|
|
(VANC) Vancomycin
|
Adenosine, Niacin, Ca blocker,causes cutaneous flushing
|
|
doxorubicin
|
daunorubicin,causes dilated cardiomyopathy
|
|
class III (sotalol) and class Ia (quinidine)
|
causes torsades de pointes
|
|
Clozapine
|
Carbamazepine, Colchine, Propylthiouracil, Methimazole, Dapsone,causes agranulocytoisis
|
|
chloramphenicol
|
benzene, NSAIDs, propylthiouracil, methimazole,causes aplastic anemia
|
|
methyldopa
|
penicillin,causes direct coombs positive hemolytic anemia
|
|
chloramphenicol
|
causes gray baby syndomr
|
|
(hemolysis IS PAIN)isoniazid
|
sulfonamides, primaquine, aspirin, ibuprofen, nitrofurantoin,causes hemolysis in G6PD-defiect patients
|
|
(females with PMS are on full BLAST mode) Phenytoin
|
Methotrexate, Sulfa drugs,causes megaloblastic anemia
|
|
OCPs like estrogen
|
Causes thrombotic complications
|
|
ACE inhibitors
|
Causes cough
|
|
Bleomycin
|
amiodarone, Busulfan,causes pulmonary fibrosis
|
|
erthryomycin
|
causes acute cholestatic hepatits, jaundice
|
|
Halothane
|
Amanita Phalloides, Valrpoic acid, Acetaminophen,causes focal to massice hepatic necrosis
|
|
isoniazid
|
causes hepatits
|
|
clindamycin
|
ampicillin,can lead to pseudomembranous colitis
|
|
glucocorticoid withdrawl via HPA suppression
|
can lead to adrenocortical insufficiency
|
|
`(Some drugs create awkward knockers) spironolactone
|
digitalis, cimetidine, chronic alcohol use, ketoconazole,can causes gynecomastia
|
|
estrogen
|
clomophene,causes hot flashes
|
|
niacin
|
tacrolimus, protease inhibitor, HCTZ, corticosteriods,causes hypergylcemia
|
|
lithium
|
amiodarone, suldonamides,causes hypothyroidism
|
|
glucocoricoids
|
protease inhibitors,causes fat redistribution
|
|
phenytoin
|
verpamil,causes gingival hyperplasia
|
|
furosemide
|
thiazides, niacin, cyclosporine,causes gout
|
|
fibrates
|
niacin, colchine, hydroxychloroquine, interferon-alpha, penicillamine, statins, glucocorticoids,causes myopathies
|
|
corticosteroids
|
heparin,causes osteoporosis
|
|
(SAT for a PHOTO) Sulfonamides
|
amiodarone, tetracycline,causes photosensitivty
|
|
penicillin
|
ethosuximide, carbamazepine, sulfa drugs, lamotrigine, allopurinol, phenytoin, phenobarbital,causes rash/SJS
|
|
Hydralazine
|
isonizid, procainamine, phenytoin,cause drug induced lupus
|
|
tetracyclines
|
causes teeth problems
|
|
fluoroquinolones
|
causes tendonitis, tendon rupture, tooth damage
|
|
lithium
|
demeclocycline,causes diabetes insipidus
|
|
expired tetracycline
|
causes fanconi's syndome
|
|
Cyclophosamide
|
ifosfamide,causes hemorrhagic cystits
|
|
methicllin
|
NSAID, furosemide,causes interstital nephritis
|
|
carbamazepine
|
cyclophosamide,causes SIADH
|
|
Quinidine
|
qunine,causes cinchonism
|
|
antipsychotics
|
resperine, metoclopramide,causes parkinson-like syndome
|
|
(with seizures
|
I BITE My tongue) isoniazid, Buproprion, imipenem, Tramadol, Enflurane, Metoclopramide,causes seizures
|
|
antipsychotics
|
causes tardive dyskinesia
|
|
Atropine
|
TCA, H1-blocker, neuoleptics,acts like an anti-muscarinic
|
|
metronidazole
|
some cephalosporins, procarbazine, 1st gen sulphonoureas,can cause a disulfiram like reaction
|
|
aminoglycosides
|
vancomycin, loop dieuetics, cisplatin,can cause nephro/ototoxicity
|
|
(Momma Barb Steals Phen-phen and Refuses Greasy Carbs Chronically)Modafinil
|
Barbiturates, St. John wart, phenytoin, rifampin, griseofulvin, carbamazepine, chronic alcohol use.,list p450 inducers
|
|
(MAGIC ROCKS in GQ) Macrolides
|
amiodarone, grapefruit juice, isoniazid, cimetidine, ritonavir actue alcohol use, ciprofloxacin, ketoconazole, sulfonamides, gemfibrozil, quinidine.,list p450 inhibitors
|
|
(Popular FACTSSS) probenacid
|
furosemide, acetazolamide, celecoxib, thiazide, sulfonamide antibiotics, sulfaasalazine, sulfonylureas,lists the sulfa drugs
|
|
G = IV and IM. V = oral.
|
Difference between peniciliin G and V.
|
|
Bind penicillin-binding proteins(transpeptidases)
|
block cross linking of peptidoglycans;most effective on G+, also N. Meningitidis, Treponema;hypersensitivy reaction, hemolytic anema.,Penicillin(mechanism,use,toxicity)
|
|
bind transpeptidases
|
penicillanse resistant due to bukly r-group blocking B-Lactamse; S. Aureus, except MRSA; hypersensitivity and interstitial nephritis.,Oxacillin,Naficillin,Dicloxacillin(mechanism,use,toxicity)
|
|
bind transpeptidases
|
wide spectrum and more penicillinase sensitive. combo with claculanic acid to protect from B-lactams;kills enterococci(HELPSS)H.iB, E.coli,Listera,Proteus,Salmonella,Shigella,enterococci;hypersensitivity reaction,rash,pseudomemrane colitis.,Ampicillin, amoxicillin(mecanism,use,toxicity)
|
|
amOxicllin has better Oral bioavilability.
|
Which has better bioavailibility; amoxicllin or ampicillin?
|
|
B-lactamse inhibitor
|
What does clavulanic acid do?
|
|
transpeptidase inhibitor but extended spectrum;pseduomonas and g- rods
|
use with claculanic acid due to B-lactamse suspectibilty; hypersensitivity reaction.,Ticarcillin,piperacillin(mechanism,use,toxicity)
|
|
(CAST) Clavulanic Acid
|
Sulbactam,Tazobactem.,List the B-lactamse inhibitors
|
|
inhibit cell wall synthesis but are less susceptible to B-lactamases
|
are bactericidal;use depends on generation, there are four;hypersensitivty reactions, vitamin K defiency, increased nephrotoxicity of aminoglycosides.,Cephalosporin(mechanism,use,toxiciity)
|
|
1st generation cephalosporins. PEcK. Proteus
|
E.coli,Klebsiella. Cefazolin used preop to prevent A.aureus infections.,give use of cefazolin, cephalexin.
|
|
2nd generation cephalosporins. HEN PEcKs. H.ib
|
Enterbacter, Neisseria, Proteus, E.coli,Klebsiella, Serratia.,give use of cefoxitin, cefaclor,cefuroxime`
|
|
3rd gen. cephalosporins. Serious gram - infections. Ceftriaxone = meningitis and gonorrhea. Ceftazidime = pseudomonas.
|
give use of ceftriaxone, cefotaxime,ceftazidime
|
|
increased activity against pseudomonas and G+ bugs.
|
give use of cefepime.
|
|
a monobactem resistant to B-lactamases
|
prevents binding to PBP3 and is synergistic with aminoglycosides;gram - rods only;very nontoxic, some GI upset.,Aztreonam(mechanism,use,toxicty)
|
|
aztreonam.
|
what transpeptidase inhibitor can be used in penicillin allergy?
|
|
broad spectrum
|
B-lactamase resistent but imipenem needs cilastatin to inhibit renal dehydropeptidase. later carbepenems do not;G+ cocci,G- rods, anerobes. used only in life threating events;skin rash, CNS toxicity, seizures.,imipenem/cilastatin,meropenem,etrapenem,doripenem(mechanism,use,toxicity)
|
|
inhibits cell wall binding peptidoglycan formation by binding D-ala percursors
|
is bacterialcidal; G+ only, especially for multidrug resistant onces;NOT - nephrotoxicity, ototoxicity, thrombophlebitis, red man syndrome.,Vancomycin(mechanism,use,toxicty)
|
|
slow infusion and rate and antihistamines.
|
How is redman syndrome prevented in vancomycin use?
|
|
amino acid change of D-ala D-ala to D-ala D-lac.
|
How does vancomycin resistant occur?
|
|
AT 30
|
CCEL at 50. 30S = Aminoglycosides, Tetracyclines. 50S = Chloramphenicol, Clindamycin, Erythromycin, Linezolid.,List antibiotic protein synthesis inhibitors
|
|
aminoglycosides
|
bacterialcidal, block translocation but require oxygen for uptake;ineffective in anaerobes,use in gram - rod infections and before bowel surgery; nephrotoxicty, NMJ block, ototoxicity, teratogen.,Gentamicin, neomycin, amikacin,tobramycin,streptomycin(mechanism,use,toxicity)
|
|
transferase enzymes that inactivate the drug by acetylation
|
phosphorylation, or adenylation.,how does resistenace to aminoglycosides occur?
|
|
bacteriostatic
|
prevents aminoacyl-tRNA binds;Borrela, M. Pneuomo, Rickettsia, Chlamysia; can't take with milk, antacids, iron because ions bind it, GI distress, discoloration of teeth, inhibition of bone growth, contraindication in pregnancy.,tetracycline, doxycycline, demecycline,minocycline(mechanism, use, toxicity)
|
|
decrease uptake into cells or increased efflux by pumps.
|
how does resistance to tetracyclines occur?
|
|
bacteriostatic
|
blocks translocation; atypical pneumonias, chlamydia, gram + cocci; MACRO: increased Motility, arrhythmia, Cholestatic hepatitis, Rash, eOsinophilia.,Azithromycin, clarithromycin, erythromycin(mechanism,use,toxicity)
|
|
methylation of 23s rRNA binding site.
|
how does resitance to macrolides occur?
|
|
Bacterialstatic
|
blocks peptidlytransferase; Meningitis in adults, used in power countries due to being cheap; dose dependent anemia, dose independent aplastic anemia, gray baby syndrome.,Chloramphenicol(mechanism,use,toxicity)
|
|
use of chloramphenicol in premature infants
|
they lack UDO-glucuronyl-transferase.,what causes grey baby syndrome?
|
|
plasmid-encoded acetyltransferase.
|
How does resistance to chloramphenicol occur?
|
|
Bacteriostatic. Blocks peptide transfer; anaerobic infections in lung infections and oral anerobes; C. Diff infection
|
fever, diarrhea.,clindamycin(mechanism,use,toxicity)
|
|
Bacteriostatic
|
PABA metabolites inhibit dihydropteroate synthase; Gram +, G-, Nocardia, Chlamydia, UTI; hypersensitivty, hemolysis in G6PD, nephrotoxic, kernicterus, displaces other drugs from albumin.,Sulfamethoxazole(SMX), sulfisoxazole, sulfadiazine(mechanism, use, toxicity)
|
|
altered bacterial dihydropteroate or increased PABA synthesis.
|
how does resistance to sulfonamides occur?
|
|
Bacteriostatic
|
inhibits bacterial dihydrofolate reductase, blocks folate synthesis; used in UTI, PCP (prophylacis and treatment), shigella, salmonella; megaloblastic anemia, leukopenia, granulocytopenia.,Trimethoprim(mechanism,use,toxicity)
|
|
bactericidal
|
inhibits DNA gyrase(topo II and IV);G- rods of urinary and GI tracts, Neisseria, some G+;( lones hurt the bones) tenonitis and tendon rupture, superinfections, don't give to kids or pregnant women due to cartilage damage.,ciprofloxacin, norfloxacin, levofloxacin, etc...(mechanism, use, toxicity)
|
|
mutation in DNA gyrase or efflux pumps.
|
how does resistance to fluroquinolones occur?
|
|
older than 60 or taking prednisone
|
What groups are susceptible to fluorquinolone tendon rupture?
|
|
bacterialcidal
|
forms free radical toxic metabolites that damge bacterial DNA damage; (GET GAP) Giardia, Entamoeba, trichomonas, Gardnerella, Anaerobes, Pylori; causes disulfiram like reaction, headache, metallic taste.,Metronidazole(mechanism, use, toxicity)
|
|
decrease synthesis of mycolic acids
|
bacterial catalase peroxidase(KatG) must activate INH; TB drug, only one used as prophylaxis and in latent TB; peripheral neuropathy, hepatoxic, lupis like drug interaction, pyridoxine antagonist.,Isoniazid(mechanism,use,toxicity)
|
|
inhibits DNA-dependent RNA polymerase; TB
|
Leprosy, prophylaxis in meningococcus and Hib type B; hepatotox, p450 inducer, orange body fluids.,Rifampin(mechanism,use,toxicity)
|
|
unknown; TB; hyperuricemia
|
hepatotoxic.,Pyrazinamide(mechanism, use, toxicity)
|
|
decreased carbohydrate polymerization of TB cell wall
|
blocks arabinosyltransferase; TB; optic neuropathy(red-green color blindness_,Ethambutol(mechanism,use,toxicity)
|
|
binds fungal ergosterol
|
causes holes in membranes; use in systemtic and CNS mycoses infections; fever/chills, hypotension, arrythmias, nephrotoxic, IV phlebitis, must supplement K and MG.,Amphotericin B(mechanism, use, toxicity)
|
|
binds fungal ergosterol;topical only due to high toxicity
|
used for oral thrush and topical diaper rash or vaginal candidiasis.,nystatin(mechanism,use,toxicty)
|
|
inhibits fungal ergosterol synthesis by binding p450;Fluconazole for suppression of cryptococcus in AIDs patients
|
itraconazle for blasto, coccio, histo.,Fluconazole, ketoconazole, clotrimazole, itraconazole, voriconazole(mechanism, use,toxicity)
|
|
inhibits fungal DNA and RNA synthesis by conversion to 5FU; used in systemic fungal infections
|
especially cryptococcus; bone marrow suppression.,Flucytosine(mechanism, use, toxicity)
|
|
inhibits fungal cell wall synthesis by inhibiting B-glucan synthesis; invasive aspergillosis
|
candida; flushing via histamine releae.,Caspofungin, micafungin(mechanism, use, toxicity)
|
|
inhibits fungal squalene epoxidase; treat dermatophytes - toe nail infection especially;abnormal LFT
|
visual disturbances.,terbinafine(mechanism,use,toxicity)
|
|
interferes with microtubules
|
stops mitosis in fungi;deposits in keratin so used in superficial infections, stops dermatophytes; teratogenic, carcinogenic, confusion, p450 inducer.,Griseofulvin(mechanism,use,toxicity)
|
|
toxoplasmosis
|
Pyrimethamine use
|
|
trypanosoma brucei
|
suramin and melarsoprol use
|
|
trypanosoma cruzi
|
nifurtimox use
|
|
leshmaniasis
|
sodium stibogluconate use
|
|
blocks formation of heme into hemozoin. Heme accumulates and is toxic to plasmodia;used on all species but falciparum(too much resitance); retinopathy
|
Chloroquine(mechanism,use,toxicity)
|
|
lifethreatening malaria
|
quinidine use
|
|
p. falciparum killing
|
artemether/lumifantrine use
|
|
inihibits influenza neuraminidase
|
stops progeny release; treamt of influenze a and b,Zanamivir,oseltamivir(mechanism,use)
|
|
inhibits sythesis of guanine nucleotides by competitvely inhibiting IMP dehydrogenase; RSV
|
chronic hep C; hemolytic anemia, severe teratogen,Ribavarin(mechanism,use,toxicity)
|
|
Guanosine analog
|
inhibits viral DNA polymerase; monophosphorylated by thymidine kinase in HSV/VZV so active in lesions and encephalitis, good for prophylaxis,"",Acyclovir,valacyclovir(mechanism, use, toxicity)
|
|
used in herpes zoster active infections
|
Famciclovir use
|
|
mutated viral thymidine kinase
|
mechanism for resistance to acyclovir
|
|
guanosine analog
|
5'-monophosphate formed by CMV viral kinase, inhibits viral DNA polymerase;CMV infections;leukopenia,neutopenia,thrombocytopenia,renal toxicity,Ganciclovir,valgangciclovir(mechanism,use,toxicity)
|
|
mutated CMV DNA polymerase or lack of viral kinase
|
mechanism for resistance to acyclovir
|
|
viral DNA polymerase inhibitor
|
binds to pyrofosphate binding site, doesn't need viral kinase activation;CMV retinitis when ganciclovir fails and acyclovir restitant HSV; nephrotoxic,Foscarnet(mechanism,use,toxicity)
|
|
mutated DNA polymerase
|
mechanism for resistance to foscarnet
|
|
inhibits DNA polymerase
|
doesn't require activiation by viral kinase; CMV retenitis, acyclovir resistant HSV; nephrotoxic(coadminister with probenacid and IV saline to reduce toxicity).,cidofovir(mechanism,use,toxicity)
|
|
[2 NRTI] +[1 NNRTI OR 1 protease inhibitor OR 1 integrase inhibitor]
|
HAART consist of what?
|
|
all end in -NAVIR! stops HIV mRNA cleavage into functional parts; hyperglycemia
|
GI upset, lipodystrophy.,give mechanism and toxicity of protease inhibitors
|
|
inhibits cytochrome p-450
|
boosting concentration of other drugs.,Ritonavir does what to be a "booster"
|
|
(NRTI)competitively blocks binding of nucleotide to reverse transcriptase
|
only tenofovir doesn't need to be activated;all NRTIs, zidovidine used in pregnancy to reduce fetal transmision; bone marrow suppression, lactic acidosis, peripheral neuropathy.,Tenofovir, emtricitabine, abacavir, lamivudine, zidovudine, didansoine, stavudine(mechanism,use,toxicity
|
|
(NNRTI) bind at a site different from NRTIs
|
no don't require activation don't compete with nucleotides; bonow marrow suppression, peripheral neuropathy, lactic acidosis,"",Nevirapine, Efavirenz, Delavirdine(mechanism,use,toxicity)
|
|
inhibits integrase
|
which stops HIV integration into host cells;HIV;hypercholesterolemia,Raltegravir(mechanism,use,toxicity)
|
|
glycoproteins synthesized my virus infected cells
|
block RNA and DNA virus replication; INFa- chronic hep b and c, Kaposi sarcoma, IFN-b -MS, INF-gamma -NADPH oxidase defiency; neutropenia, myopathy.,Interferons(mechanism,use,toxicity)
|
|
SAFe Children Take Really Good Care. sulfonamides(kericterus)
|
aminoglycosides(ototox), fluoroquinolones(cartilage damage), Clarithromycin(embryotoxic), Tetracycline(teeth,bone damage),Ribavarin(teratogenic),Griseofulvin(teratogenic),Chloramphenicol(grey baby),What antibiotics must be avoided in pregnancy?
|
|
vincristine and paclitaxil
|
cause direct toxicity to nerves
|
|
isoniazid structurally similar to B6
|
which causes renal excretion of B6 and competes for B6 binding sites.,By what mechanism does isoniazid cause B6(pyridoxine) loss?
|
|
antihistamines and antipyretics.
|
What medications can be given before Amphotercin B infusion to lessen side effects?
|
|
digoxin causes hyperkalemia. HOWEVER
|
a HYPOkalemic state increses patient susceptibility to digoxin toxicity.,Does digoxin cause hyper or hypokalemia? which states increases patient susceptibility to digoxin toxicity?
|
|
ataxia
|
slurred speech, somnolence, vomiting,list signs of ammonia overdose
|
|
bleomycin
|
busulfan, amiodarone, methotrexate,cause restrictive lung disease
|
|
loop diuretics: increased urine Ca via decreased reabsorption. thiazides: decreased urine Ca.
|
Contrast urine Ca with loop diuretics and thiazides
|
|
Serum gamma-glutamyltransferase.
|
What is a sensitive indicator of alcohol abuse?
|
|
benzodiazepenes
|
What is the treatment for delirium tremens?
|
|
The naloxone is only active if inected
|
making it hard to abuse the combo.,Why is the naloxone-buprenorphine combo used for heroin addiction treatment?
|
|
rigidity
|
myoglobinuria, autonomic instability. seen with antipsychotics overdose. treatment: dantrolene and bromocriptine (d2 agonist),What is neuroleptic malignant syndrome? What is the treatment?
|
|
sterotypical oral-facial movements
|
from long term antipsychotic use. often NOT reversible.,What is tardive dyskinesa? Is it reversible?
|
|
occurs with any drug that increases serotonin (MAO inhibitor
|
SNRI, TCA) hyperthermia, confusion, myoclonus, cardio collapse, flushing. tx: cyproheptadine (5ht antagonist),What is serotonin syndrome? what is the treatment?
|
|
Translitional cell carcinoma of the bladder
|
What can long term Phenactin use cause?
|
|
renal damage
|
What are the teratogenic effects of ACE inhibitors?
|
|
absence of digits
|
toes,What are the teratogenic effects of alkylating agents?
|
|
CV VIII toxicity
|
What are the teratogenic effects of aminoglycosides?
|
|
neural tube defects
|
craniofacial defects,What are the teratogenic effects of carbamazepine?
|
|
vaginal clear cell adenocarcinoma
|
congenital mullerian anomalies,What are the teratogenic effects of diethylstilbestrol?
|
|
neural tube defects
|
What are the teratogenic effects of folate antagonists?
|
|
ebstein's anomaly -> atrialized right ventricle
|
What are the teratogenic effects of lithium?
|
|
fetal hydantoin syndrome->microcephaly
|
dysmorphic face,What are the teratogenic effects of phenytoin?
|
|
discolored teeth
|
What are the teratogenic effects of tetracyclines
|
|
limb defects like flipper arms
|
What are the teratogenic effects of thalidomide
|
|
inhibitor of maternal folate absorption ->neural tube defects
|
What are the teratogenic effects of valproate?
|
|
bone deformities
|
fetal hemorrhage, abortion,What are the teratogenic effects of warfarin?
|
|
3rd -8th week.
|
At what time period is a fetus most susceptable to teratogens?
|
|
extremely high risk for spontaneous abortion
|
What are the teratogenic effects of vitamin a?
|
|
placental abruption
|
developmental abnormalities,What are the teratogenic effects of cocaine?
|
|
preterm labor
|
placental problems, ADHD,What are the teratogenic effects of smoking?
|
|
alcohol
|
What drug is the leading cause of birth defects and mental retardation?
|
|
(OH DANG) Ototox
|
hypokalemia, dehydration, allergy(sulfa), Nephritis, Gout,What are the toxicities of Loop diuretics?
|
|
(hyperGLUC) hyperglycemia
|
hyperlipidemia, hyperuricemia, hypercalcemia.,What are the toxicites of HCTZ?
|
|
1. Volume contraction ->AT II increases ->increased bicarb absorbed in PT. 2. K loss leads to K leaving all cells and thus H entering all cells. 3. in a low K state
|
H is exchanged instead of K for Na in the CCT leading to paradoxical aciduria.,By what mechanisms do thiazides and loop diutetics cause metabolic alkalosis?
|
|
OCP and dopemaine antagonists (antipsychotics)
|
What drugs can stimulate prolactin secretion?
|
|
PTU disables peroxidase AND 5'-deiodinase. Methimazole only inhibits peroxidase.
|
What is a difference in the mechanism of PTU and methimazole?
|
|
NO
|
they require some islet function to release insulin. type 1 - those cells are dead.,Can sulfonylureas be used in type 1 DM?
|
|
Insulins
|
amylin analongs(pramlintide).,What drugs can be used to treat type 1 AND 2 DM?
|
|
allopurinol stops urate crystal collection -> no gout.
|
What drug is used to prevent tumor lysis urate neuropathy?
|
|
acute: NSAID
|
indomethicin. Chronic: allopurinol, febuxostat, probenacid, colchicine,List acute and chronic gout drugs.
|
|
used in chronic gout; inhibits reabsorption of uric acid in the proximal tubule; inhibits secretion of penicillin; do NOT use in renal dysfunction.
|
probenacid(mechanism, use, tox)
|
|
used in chronic gout
|
inhibits xanthine oxidase.,febuxostat(use, mechanism)
|
|
binds to G- cell membrane phospoholipids
|
disrupting them; only works in g-; peripheral neuropathy, dizziness, nsytagmus, nephrotoxicity.,Polymixin B(mechanism, use, toxicity)
|
|
increase catecholamines at synaptic cleft
|
especially NE + dopamine; ADHD, nacrolepsy, appetite control,Methylphenidate, destroamphetamine, methamphetamine(mechanism, use)
|
|
this is vitamin K
|
used in warfarin overdose,Phytonadione(use)
|
|
folinic acid
|
it is a metabolite of folic acid; given with methotrexate to replish the body's folate stores.,Leucovorin(use,mechanism)
|
|
antidote to heparin overdose. Protamine is a postive ion that binds to negative heparin
|
inactivating it.,Protamine sulfate (use, mechanism)
|
|
When someone taking MAO inhibitors eats hard cheeses and drinks wine
|
causing a crisis.,What is tyramine crisis caused by?
|
|
it has a MUCH longer half life
|
plus it is irrversible while phentolamine is reversible,Why is phenoxybenzamine prefered over phentolamine for presurgery pheochromocytoma surgery?
|
|
It is broken down in the gut into an acid. This acid acts as both as osmotic (draws out some ascites) and also it gets rid of excess ammonia
|
which is causing the encephalopathy.,Why is Lactulose fed to people with hepatic encephalopathy?
|
|
Complement inhibitor
|
used in Paroxysmal Nocturnal Hemoglobinuria.,Eculizumab(mechanism, use)
|
|
adenosine analog
|
used in treatment of hairy cell leukemia,Cladribine(mechanism, use)
|
|
Used in treating the M3
|
promyelocytic subtype of AML.,Trans-retinoic acid(use)
|
|
Yes
|
they lower GFP by stopping efferent arteriole constrinction. Creatinine can increase up to 30% and should peak by 1 weak. This can be BAD in renal artery stenosis, where ACE II is what is keeping the kidney alive.,Is an increase in serum creatinine normal after starting ACE inhibitors?
|
|
causes depolarization of cellular membrane; used in invasive MRSA; myopathy
|
raised CPK, inactivated by pulmonary surfactant,Daptomycin(mechanism, use, toxicity)
|
|
chemoreceptor trigger zone (area postrema)
|
the solitary nucleus, and in the presynpatic vagus nerve.,Ondansetron acts on 5HT3 receptors in what location, in order to decrease nausea?
|
|
They cause constriction of the spinchter of oddi -> increased billiary pressures -> billiary colic.
|
Why must mu agonists be avoided in suspected pancreatic or biliary pain?
|
|
trimethoprim
|
methotrexate, pyrimethamine.,What drugs inhibit dihydrofolate reductase?
|
|
partial agonist for nicotinic aCh channels in CNS. fights with ciggeratte nicotine for channel. reduces nicotine withdrawl cravings while attenuating the rewarding effects.
|
Varenicline(mechanism, use)
|
|
antidepressants
|
What class of drug can precipitate mania in those with bipolar disorder?
|
|
Desmopression (sleep enuresis = bed wetting)
|
What is the treatment for sleep enuresis?
|
|
furosemide. TAL of Henlee absorbs the most NA here compared to where over diuretics work. will reduce edema quickly.
|
In general, what is the best drug to use for edema of any kind?
|
|
PTU does. Methimazole does NOT.
|
Which drug used for hyperthyroidism decreases peripheral T3->T3 conversion?
|
|
NO. G cells are under vagal influence but they do not use ACh as a neurotransmitter. Instead
|
they use GRP.,Can atropine be used to block gastric secretions? why or why not?
|
|
Inhibits alcohol dehydrogenase; used as an antidote to methanol or ethylene glycol poisoning.
|
Fomepizole(mechanism, use)
|
|
Inhibits acetaldehyde dehydrogenase
|
makes acetaldehyde accumulate leading to hanger; used in alcohol abuse.,Disulfiram(mechanism, use)
|
|
Benzoate or Phenylbutyrate will bind amino acids and lead to excretion.
|
What can be given to those suffering from hyperammonia caused by a metabolic derangement?
|
|
On first dose
|
patient gets severe hypotension. Correct this by starting with a small dose.,What is first dose effect, typically seen in A1 blockers?
|
|
Isosorbide mononitrate can be swallowed. It has an almost 100% biavailability that way. Others cannot due to first pass metabolism.
|
Which nitrate can be given PO?
|
|
Stops chemotaxis of neutrophils
|
Colchine stops what specific cell to decrease gout symptoms?
|
|
methlydopa
|
What is the first line drug used to treat hypertension in pregnancy?
|
|
All S. Aureus has Beta-lactamases. Naficillin fights this. But MRSA has this AND altered penicillin binding proteins
|
which prevents Naficillin from working in MRSA.,Why is MRSA resistant to Naficillin but normal S. Aureus is not?
|
|
antibody against F protein
|
prevents pneumonia from RSV in infants,Palizumab(mechanism, use)
|
|
IgG anti-RH antibodies. given to mom at 28 weeks and also at birth
|
it sticks to the RH antigens in the MOM's blood, keeping her from developing antibodies.,Rhogam(mechanism, use)
|
|
COMT blockers
|
which increase DOPA levels; Both stop peripheral methylation and only Tolcapone stops central methylation; tolcapone causes hepatotoxicity,Entacapone, Tolcapone (mechanism, use, tox)
|
|
Constipation
|
What opioid effect is most resistant to tolerance?
|
|
IL 2; used in RCC
|
metastaic melanoma,Aldesleukin (mechanism, use)
|
|
erythropoietin; anemias
|
especially in renal failure,Epoetin Alfa(mechanism, use)
|
|
Fil = GC-SF
|
Sar = GM-CSF; both used in recovery of bone marrow, aplastic anemia,Filgrastim, Sargramostim (mechanism, use)
|
|
hepatitis B and C
|
Kaposi sarcoma, Leukemias, Malignany Melanoma,alpha-inerferon(use)
|
|
Multiple sclerosis
|
B-Interferon(use)
|
|
Chronic Granulamatous disease
|
gamma-interferon(use)
|
|
IL-11; thrombocytopenia
|
Oprelvekin(mechanism, use)
|
|
thrombocytopenia
|
thromopoietin(use)
|
|
antibody to CD3; used in acute transplant rejection
|
Muromonab-CD3 (mechanism, use)
|
|
antibody to digoxin; used as antidote to digoxin intoxication
|
Digoxin Immune Fab(mechanism, use)
|
|
Recombinat version of Urate oxidase
|
breaks uric acid down into allantoin; use in tumor lysis syndrome and gout,Rasburicase (mechanism, use)
|
|
monoclonal anitbody that binds to RANKL and prevents its interaction with RANK
|
inhibiting osteoclasts; decreases bone loss in bone mets,denosumab(mechanism, use)
|
|
It's high water solubility. Things with a high lipid solubility (unconjugated bilirubin) tend to cross the placenta while things with high water solubility(conjugated bilirubin) tend to not. binds albumin = probably lipid soluble
|
What keeps heparin from crossing the placental barrier?
|
|
Used in transplant anti-rejected
|
treatment of graft-vs-host disease, and psoriasis; binds calineurin on T cells, stopping IL2 from being expressed, lowering T cell response; nephtrotox and lymphomma risk,cyclosporine(mechanism, use, toxicity)
|
|
a retinoid that has immunomodulatory effects
|
binds nuclear receptors; psorisias and acne; severe teratogen,Isotretinoin, tretinoin, Acitretin(mechanism,use,toxicity
|
|
vitamin D analog; used in topical psoariasis treatment
|
Calcipotrol(mechanism, use)
|
|
Inhibits intestinal lipase
|
decreasing fat absorption; used to treat obesity,Orlistat(mechanism, use)
|
|
aspirin. Niacin increases prostaglandin D2. release. asprin blocks this release = lower flushing
|
giving what drug 30 minutes before Niacin can help reduce flushing?
|
|
Prevent growth of intima by inhibiting cellular growth = no restenosis
|
Paclitaxil or sirolimus are commonly used in cardiac stents. why?
|
|
IV magnesium sulfate for seizures
|
What is the drug used for Pre-eclampsi and ecplamsia?
|
|
Protease inhibitor
|
proteases are overactive in some cancers and can destroy pro-apototic proteins; used in multiple myeloma; peripheral neuropathy,Bortezomib(mechanism,use, toxicity)
|
|
Nitroprusside degrades into cyanide. Give thiosulfide to inactivate.
|
What causes nitroprusside toxicity? What is the antidote?
|
|
blocks NMDA-type glutamate receptors; used in alzheimers; confusion
|
Memantine(mechanism, use, toxicity)
|
|
Vitamin E (generic name is alpha-tocopherol)
|
What vitamin is used in alzheimer's treatment?
|
|
Lipid solubility = potency (MAC). Blood solubility = speed of induction.
|
In gas anesthesias, what is the lipid solubility and the blood solubility?
|
|
topical vitamin D analogs
|
activate nuclear receptors that inhibit keratinocyte proliferation and enhance keratinocyte differentiation; psoriasis,Calcitrol, calcipotriene, tacalcitol (mechanism, use)
|
|
monoclocal antibody that binds IL-12 and IL-12 thus inhibiting activation of Th1 cd4+ t cells; used in psoriasis
|
Usetekinumab(mechanism, use)
|
|
MAO-inhbitors (phenelzine) inactive the MAO-I enzymes. It takes 2 weeks for them to get re-synthesized. If both SSRI and MAO-I are active at the same time
|
serotonin syndrome could occur,Why is it required to wait 14 days after stoping a MAO-i before starting an SSRI?
|
|
from leeches
|
inhibit thrombin; used as an alternative to heparin in HIT.,Lepirudin, Bivalirudin (mechanism, use)
|
|
are D2 agonists that DON'T need to be activated like l-dopa does; used in parkinsons and restless leg syndrome
|
Ropinirole, Pramipexole (mechanism, use)
|
|
indirect and direct D agonist
|
also some anticholingergic functions which reduces tremors,what are the uses of amantidine for parkinsons?
|
|
sodium metabisulite
|
found as a food additive and sanitizer,What compound can cause sickling of sickle cell trait RBC's?
|
|
They act on D4 instead of D2 receptors -> no risk of tardive dyskinesia or parkinson's like symptoms
|
How do atypical antipsychotics avoid causing parkinson's symptoms and tardive dyskinesia?
|
|
Celecoxib. It only impairs COX2. COX1 is predominate in platlets.
|
Which anti-inflammatories will not impair platlet aggregation? why?
|
|
binds alpha-4 integrin
|
which blocks movement of WBC into orgrans;used in crohns and MS; can cause PML and hepatotoxicity.,Natalizumab(mechanism, use, toxicity)
|
|
Anti-muscarinics (Benzotropine). Giving dopamine agonists would exacerbate psychosis.
|
What drugs are preferred in medication induced parkinson's treatment? why?
|
|
induction = lower solubility in blood
|
quicker induction. potency = higher with higher lipid solubility =1/MAC.,What defines induction and potency in gas anesthetics?
|
|
Nitrates (mechanism
|
use, toxicity),Cause NO release -> vasodilation (veins >>> arteries); used in angina; fast tolerance, hypotension, flushing, headache Pharmacology Cardio
|
|
Adverse effects of statins
|
Hepatoxicity and muscle breakdown Pharmacology Cardio
|
|
Niacin (mechanism
|
use, toxicity),Inhibits lipolysis and reduces VLDL secretion, lowering LDL and raising HDL; hyperlipidemia; flushing and hyperuricemia Pharmacology Cardio
|
|
Cholestyramine
|
colestipol, colesevelam (mechanism, use, toxicity),Inhibits reabsorption of bile acids -> lower LDL with slight increase in HDL; unpigmented gallbladder stones and malabsorption Pharmacology Cardio
|
|
Ezetimibe
|
Prevents cholesterol reabsorption -> lower LDL Pharmacology Cardio
|
|
Fibrates (gemfibrozil + -fibrates) (mechanism
|
use, toxicity),Upregulates LPL -> lower triglycerides, slightly inc. HDL and slightly dec. LDL; myositis and hepatoxicity Pharmacology Cardio
|
|
Digoxin and digitoxin (mechanism
|
use, toxicity),Inhibits Na/K ATPase -> indirectly inhibits Na/Ca exchanger -> inc. calcium levels -> inc. contractility; stimulates the vagus; causes cholinergic symptoms and hyperkalemia Pharmacology Cardio
|
|
Class 1A antiarrhythmics
|
Quinidine, procainamide, and disopyramide; inc. AP duration and QT interval; can cause torsades de pointes, cinchonism (qunidine), procainamide (drug-induced lupus) Pharmacology Cardio
|
|
Class 1B antiarrhythmics
|
Lidocaine, mexiletine, and tocainide; dec. AP duration especially in depolarized/ischemia tissue; best following MI Pharmacology Cardio
|
|
Class 1C antiarrhythmics
|
Flecainide, propafenone; no effect on AP, used in ventricular tachycardias; do not use post-MI due to risk for arrhythmias Pharmacology Cardio
|
|
Class 1 antiarrhythmics (general mechanism and toxicity)
|
Blocks Na channels, decreasing the slope of phase 0 depolarization; toxicity exacerbated by hyperkalemia Pharmacology Cardio
|
|
Class 2 antiarrhythmics
|
Beta-blockers; reduces cAMP, slowing SA and AV node activity, increases PR interval; adverse effects include impotence, asthma exacerbation, sedation Pharmacology Cardio
|
|
Class 3 antiarrhythmics
|
Amiodarone, ibutilide, dofetilide, sotalol; K channel blockers; inc. AP duration and QT interval Pharmacology Cardio
|
|
Toxicity of amiodarone
|
Pulmonary fibrosis, hepatotoxicity, thyroid dysfunction Pharmacology Cardio
|
|
Class 4 antiarrhythmics
|
Ca channel blockers; verapamil and diltiazem; dec. conduction velocity and inc. PR interval; cause constipation, flushing, and edema Pharmacology Cardio
|
|
Adeosine (mechanism
|
use, toxicity),Inc. K efflux, hyperpolarizing the cell; used in supraventricular tachycardias; can cause flushing, hypotension, and chest pain Pharmacology Cardio
|
|
Magnseium (mechanism
|
use, toxicity),Used in torsades de pointes and digoxin toxicity Pharmacology Cardio
|
|
Treatment for prolactinoma
|
Bromocriptine or cabergoline (dopamine agonists) Pharmacology Endocrine
|
|
Treatment of secondary hyperaldosteronism
|
Spironolactone (or other AT2 antagonist) Pharmacology Endocrine
|
|
Treatment of carcinoid syndrome
|
Octreotide (somatostatin analogues) Pharmacology Endocrine
|
|
Rapid-acting insulins (3)
|
Lispro, aspart, and glulisine Pharmacology Endocrine
|
|
Short-acting insulin (1)
|
Regular Pharmacology Endocrine
|
|
Intermediate-acting insulin (1)
|
NPH Pharmacology Endocrine
|
|
Long-acting insulins (2)
|
Glargine and detemir Pharmacology Endocrine
|
|
Metformin (mechanism
|
use, toxicity),Biguanide; unknown mechanism; increases insulin sensitivity and glycolysis and decreases gluconeogenesis; can cause lactic acidosis (don't use in renal failure patients) Pharmacology Endocrine
|
|
Tolbutamide
|
chlorpropamide (mechanism, use, toxicity),First-generation sulfonylureas; close beta-cell K channels, causing depolarization and increased insulin release; causes disulfuram-like effects Pharmacology Endocrine
|
|
Glyburide
|
glimepiride, glipizide (mechanism, use, toxicity),Second-generation sulfonylureas; close beta-cell K channels, causing depolarization and increased insulin release; causes hypoglycemia Pharmacology Endocrine
|
|
Pioglitazone
|
rosiglitazone (mechanism, use, toxicity),Thiazolidinediones; activates PPAR-gamma, increasing insulin sensitivity and adiponectin levels; causes weight gain, hepatotoxicity, and heart failure Pharmacology Endocrine
|
|
Acarbose
|
miglitol (mechanism, use, toxicity),Alpha-glucosidase inhibitors; prevent sugar hydrolysis and absorption, reducing blood sugar levels Pharmacology Endocrine
|
|
Pramlintide (mechanism
|
use, toxicity),Amylin analog; reduces glucagon secretion; causes hypoglycemia Pharmacology Endocrine
|
|
Exenatide
|
liraglutide (mechanism, use, toxicity),GLP-1 analogues; increase insulin, decrease glucagon secretion; causes pancreatitis Pharmacology Endocrine
|
|
Linagliptin
|
saxagliptin, sitagliptin (mechanism, use, toxicity),DPP-4 inhibitors; increase insulin, decrease glucagon secretion; causes mild urinary/respiratory infections Pharmacology Endocrine
|
|
Propylthiouracil (mechanism
|
use, toxicity),Blocks thyroid peroxidase and 5'-deiodinase; used to treat hyperthyroidism; causes agranulocytosis, aplastic anemia, hepatotoxicity Pharmacology Endocrine
|
|
Methimazole (mechanism
|
use, toxicity),Blocks thyroid peroxidase; used to treat hyperthyrodism; teratogenic Pharmacology Endocrine
|
|
Levothyroxine
|
triiodothyronine (mechanism, use, toxicity),Thyroid hormone analogs; causes thyrotoxicosis Pharmacology Endocrine
|
|
Oxytocin (mechanism
|
use, toxicity),Used to control uterine hemhorrage Pharmacology Endocrine
|
|
Demeclocycline (mechanism
|
use, toxicity),ADH antagonist used to treat SIADH; can cause photosensitivty and bone/teeth abnormalities Pharmacology Endocrine
|
|
Glucocorticoids (mechanism
|
use, toxicity),Inhibits phospholipase A2 activity and expression of COX-2; used for immune suppression; can cause Cushing's syndrome, adrenal insufficiency (if withdrawn quickly) Pharmacology Endocrine
|
|
Cimetidine and ranitidine (mechanism
|
use, toxicity),H2 antagonists; used to treat hyperchloridia; cimeditine is a P-450 inhibitor and has antiandrogenic effects, both reduce creatinine secretion Pharmacology GI
|
|
-prazoles (mechanism
|
use, toxicity),Irreversibly inhibit the H/K pump; used to treat hyperchloridia; increased risk of C. difficile infection and hypomagnesemia Pharmacology GI
|
|
Bismuth
|
sucralfate (mechanism, use, toxicity),Coats ulcer base and protects underlying tissue Pharmacology GI
|
|
Misoprostol (mechanism
|
use, toxicity),PGE1 analog that decreases acid production and increases bicarb production; used to prevent NSAID ulcers; abortifacient Pharmacology GI
|
|
Octreotide (mechanism
|
use, toxicity),Somatostatin analog; used to treat VIPoma and carcinoid syndrome Pharmacology GI
|
|
Toxicity of long-term antacid use
|
Hypokalemia Pharmacology GI
|
|
Infliximab (mechanism
|
use, toxicity),Anti-TNF; used to treat IBD and RA; can cause activation of latent microbes Pharmacology GI
|
|
Sulfasalazine (mechanism
|
use, toxicity),Combination of sulfapyridine (antibacterial) and 5-aminosalicylic acid (anti-inflammatory); used to treat IBD; causes oligospermia Pharmacology GI
|
|
Ondansetron (mechanism
|
use, toxicity),5-HT3 antagonist; used as an antiemetic Pharmacology GI
|
|
Metoclopramide (mechanism
|
use, toxicity),D2 antagonist; used to increase gut muscle activity and as an antiemetic; causes parkinson signs Pharmacology GI
|
|
Can be used to prevent mast cell degranulation
|
Cromolyn sodium Pharmacology Heme/Onc
|
|
Treatment of lead poisoning
|
Dimercaprol and EDTA, succimer in kids Pharmacology Heme/Onc
|
|
Heparin (mechanism
|
use, toxicity),Activates antithrombin, which inactivates thrombin and Xa; used for immediate coagulation and in pregnant women; some patients develop antibodies to platelet factor 4 (HIT) Pharmacology Heme/Onc
|
|
Enoxaparin
|
dalteparin (mechanism, use, toxicity),Same actions as heparin, but has a longer half-life, does not have to be monitored as closely, and has a reduced risk of HIT Pharmacology Heme/Onc
|
|
Warfarin (mechanism
|
use, toxicity),Inactivated gamma-carboxylation of factors II, VII, IX, X, C, and S; used for long-term and non-immediate anticoagulation; can cause tissue necrosis, teratogenic Pharmacology Heme/Onc
|
|
Alteplase
|
reteplase, tenecteplase (mechanism, use, toxicity),Converts plasminogen to plasmin; used as a thrombolytic Pharmacology Heme/Onc
|
|
Aspirin (mechanism
|
use, toxicity),Irreversibly inhibits COX-1 and COX-2; anti-platelet and anti-inflammatory; gastric ulcers, tinnitus, Reye's syndrome in childhood viral infections Pharmacology Heme/Onc
|
|
Clopidogrel
|
ticlodipine, prasugrel, ticagrelor (mechanism, use, toxicity),Irreversibly blocks ADP receptors on platelets, preventing degranulation; used for acure coronary syndrome; ticlodipine causes neutropenia Pharmacology Heme/Onc
|
|
Cilostazol
|
dipyridamole (mechanism, use, toxicity),Phosphodiesterase inhibitor, increases cAMP and decreases ADP, preventing platelet degranulation; nausea, headache, facial flushing, hypotension Pharmacology Heme/Onc
|
|
Abciximab
|
eptifibatide, tirofiban (mechanism, use, toxicity),GPIIb/IIIa inhibitors, preventing platelet aggregation; bleeding, thrombocytopenia Pharmacology Heme/Onc
|
|
Methotrexate (mechanism
|
use, toxicity),Inhibits dihydrofolate reductase, inhibiting DNA synthesis; myelosuppression, macrovesicular fatty change in liver Pharmacology Heme/Onc
|
|
5-fluorouracil (mechanism
|
use, toxicity),Pyrimidine analog that is activated and inhibits thymidylate synthase, inhibiting DNA synthesis; myelosuppression, photosensitivity Pharmacology Heme/Onc
|
|
Cytarabine (mechanism
|
use, toxicity),Pyrimidine analog that inhibits DNA polymerase; leukopenia, thrombocytopenia, megaloblastic anemia Pharmacology Heme/Onc
|
|
Azathioprine
|
6-mercaptopurine, 6-thioguanine (mechanism, use, toxicity),Purine analogs that are activated by HGPRT and inhibit purine synthesis; toxicity is increased with allopurinol, causes bone marrow, GI, and liver toxicity Pharmacology Heme/Onc
|
|
Dactinomycin (actinomycin D) (mechanism
|
use, toxicity),DNA intercalator; used for childhood tumors; myelosuppression Pharmacology Heme/Onc
|
|
Doxorubicin (Adriamycin)
|
daunorubicin (mechanism, use, toxicity),Generates free radicals that cause DNA strand breaks; dilated cardiomyopathy, myelosuppression, alopecia Pharmacology Heme/Onc
|
|
Bleomycin (mechanism
|
use, toxicity),Generates free radicals that cause DNA strand breaks; pulmonary fibrosis with minimal myelosuppression Pharmacology Heme/Onc
|
|
Cyclophosphamide
|
ifosfamide (mechanism, use, toxicity),Crosslinks DNA (must be activated by liver); myelosuppression, hemhorragic cystitis (can be minimized with mesna) Pharmacology Heme/Onc
|
|
Carmustine
|
lomustine, semustine, streptozocin (mechanism, use, toxicity),Used to treat CNS tumors Pharmacology Heme/Onc
|
|
Busulfan (mechanism
|
use, toxicity),Alkylates DNA; pulmonary fibrosis, hyperpigmentation Pharmacology Heme/Onc
|
|
Vincristine
|
vinblastine (mechanism, use, toxicity),Block microtubule polymerization; vincristine causes neurotoxicity, vinblastine causes bone marro suppression Pharmacology Heme/Onc
|
|
Paclitaxel (mechanism
|
use, toxicity),Blocks microtubule breakdown; myelosuppression Pharmacology Heme/Onc
|
|
Cisplatin
|
carboplatin (mechanism, use, toxicity),Crosslinks DNA; nephrotoxicity (minimize with chloride diuresis, amifostine), acoustic n. damage Pharmacology Heme/Onc
|
|
Etoposide
|
teniposide (mechanism, use, toxicity),Inhibits topoisomerase II; myelosuppression, GI upset, alopecia Pharmacology Heme/Onc
|
|
Hydroxyurea (mechanism
|
use, toxicity),Inhibits ribonucleotide reductase; used in cancers and HbSS disease; bone marrow suppression Pharmacology Heme/Onc
|
|
Prednisone (mechanism
|
use, toxicity),Unknown but may trigger apoptosis in dividing cells; Cushingoid symptoms Pharmacology Heme/Onc
|
|
Tamoxifen
|
raloxifene (mechanism, use, toxicity),Prevents estrogen receptor binding; used in breast cancer and prevention of osteoporosis; tamoxifen increases the risk of endometrial cancer due to agonist effects Pharmacology Heme/Onc
|
|
Trastuzumab (mechanism
|
use, toxicity),Antibody against HER-2 receptor; cardiotoxicity Pharmacology Heme/Onc
|
|
Imatinib (mechanism
|
use, toxicity),Antibody against bcr-abl tyrosine kinase Pharmacology Heme/Onc
|
|
Rituximab (mechanism
|
use, toxicity),Antibody against CD20; used to treat non-Hodgkin's lymphoma and rheumatoid arthritis Pharmacology Heme/Onc
|
|
Vemurafenib (mechanism
|
use, toxicity),B-raf kinase inhibitor (V600 mutation); used in metastatic melanoma Pharmacology Heme/Onc
|
|
Bevacizumab (mechanism
|
use, toxicity),Antibody against VEGF Pharmacology Heme/Onc
|
|
Ibuprofen
|
naproxen, indomethacin, ketorolac, diclofenac (mechanism, use, toxicity),Reversible COX inhibitor; gastric ulcers, renal ischemia (due to constriction of afferent arteriole) Pharmacology Musculoskeletal
|
|
Celecoxib (mechanism
|
use, toxicity),Reversible COX-2 inhibitor; anti-inflammatory without damage to gastric mucosa; sulfa allergy, thrombosis Pharmacology Musculoskeletal
|
|
Acetominophen (mechanism
|
use, toxicity),COX inhibitor in the CNS (not anti-inflammatory); causes hepatic necrosis Pharmacology Musculoskeletal
|
|
Alendronate (mechanism
|
use, toxicity),Pyrophosphate analog that inhibits osteoclasts; used to treat osteoporosis, hypercalcemia, and Paget's disease; corrosive esophagitis Pharmacology Musculoskeletal
|
|
Allopurinol (mechanism
|
use, toxicity),Xanthine oxidase inhibitor, reduces production of uric acid Pharmacology Musculoskeletal
|
|
Febuxostat (mechanism
|
use, toxicity),Xanthine oxidase inhibitor Pharmacology Musculoskeletal
|
|
Probenecid (mechanism
|
use, toxicity),Inhibits reabsorption of uric acid in PCT Pharmacology Musculoskeletal
|
|
Colchine (mechanism
|
use, toxicity),Inhibits microtubule polymerization, preventing neutrophil extravasation Pharmacology Musculoskeletal
|
|
Etanercept (mechanism
|
use, toxicity),TNF-alpha receptor that binds free TNF-alpha Pharmacology Musculoskeletal
|
|
Infliximab
|
adalimumab (mechanism, use, toxicity),Anti-TNF-alpha antibody Pharmacology Musculoskeletal
|
|
Latanoprost (mechanism
|
use, toxicity),PGF2 analog that increases the outflow of aqueous humor; can cause darkening of the iris Pharmacology Neurology
|
|
Morphine
|
fentanyl, cofeine, heroin, methadone, meperidine, dextromethorphan, diphenoxylate (mechanism, use, toxicity),Mu opioid agonists that open K channels and close Ca channels, inhibting synaptic transmission; addiction, respiratory depression, constipation, miosis Pharmacology Neurology
|
|
Butorphanol (mechanism
|
use, toxicity),Mu opioid partial agonist; used to treat severe pain; causes withdrawal if being treated with full agonist Pharmacology Neurology
|
|
Tramadol (mechanism
|
use, toxicity),Weak opioid agonist that inhibits serotonin and NE reuptake; increases risk for seizures Pharmacology Neurology
|
|
First-line therapy for simple partial seizures
|
Carbamazepine Pharmacology Neurology
|
|
First-line therapy for complex partial seizures
|
Carbamazepine Pharmacology Neurology
|
|
First-line therapies for tonic-clonic seizures (3)
|
Carbamazepine, phenytoin, valproate Pharmacology Neurology
|
|
First-line therapy for absence seizures
|
Ethosuximide Pharmacology Neurology
|
|
Phenytoin (mechanism
|
use, toxicity),Increases Na channel inactivation and inhibits glutamate release; used for simple, complex, and tonic-clonic seizures and status epilecticus prophylaxis; nystagmus, gingival hyperplasia, hirsutism, megaloblastic anemia, teratogenic, drug-induced lupus, P450 inducer Pharmacology Neurology
|
|
Carbamazepine (mechanism
|
use, toxicity),Increases Na channel inactivation; first-line for simple, complex, and tonic-clonic seizures and trigeminal neuralgia; agranulocytosis, aplastic anemia, P450 inducer, SIADH, liver toxicity Pharmacology Neurology
|
|
Lamotrigine (mechanism
|
use, toxicity),Blocks Na channels; used for simple, complex, and tonic-clonic seizures; Steven-Johnson syndrome Pharmacology Neurology
|
|
Gabapentin (mechanism
|
use, toxicity),Inhibits Ca channels; used for simple, complex, and tonic-clonic seizures, migraine prophylaxis, peripheral neuropathy, bipolar disorder; ataxia Pharmacology Neurology
|
|
Topiramate (mechanism
|
use, toxicity),Blocks Na channels and increases GABA secretion; used for simple, complex, and tonic-clonic seizures and migraine prevention; mental dulling, kidney stones, weight loss Pharmacology Neurology
|
|
Phenobarbital (mechanism
|
use, toxicity),Increases GABA channel action; first-line for simple, complex, and tonic-clonic seizures in children; P450 inducer Pharmacology Neurology
|
|
Valproate (mechanism
|
use, toxicity),Increases Na channel inactivation and increases GABA levels; first-line for tonic-clonic seizures, used for simplex, complex, tonic-clonic, and myoclonic seizures; hepatotoxicity, neural tube defects, weight gain, tremor Pharmacology Neurology
|
|
Ethosuximide (mechanism
|
use, toxicity),Blocks thalamic Ca channels; first-line for absence seizures; GI distress, Steven-Johnson syndrome Pharmacology Neurology
|
|
Benzodiazepines (mechanism
|
use, toxicity),Increases frequency of GABA channel opening; first-line for status epilepticus (diazepam, lorazepam), used for eclampsia seizures (diazepam, lorazepam), anxiety, alcohol withdrawl, sleep walking, night terrors; sedation Pharmacology Neurology
|
|
Tiagabine (mechanism
|
use, toxicity),Inhibits GABA reuptake; used for simple and complex seizures Pharmacology Neurology
|
|
Vigabatrin (mechanism
|
use, toxicity),Irreversibly inhibits GABA transaminase, increasing GABA concentration; used for simple and complex seizures Pharmacology Neurology
|
|
Levetriacetam (mechanism
|
use, toxicity),Unknown mechanism; used for simple, complex, and tonic-clonic seizures Pharmacology Neurology
|
|
Phenobarbital
|
pentobarbial, thiopental, secobarbital (mechanism, use, toxicity),Increase duration of GABA channel opening; induction of anesthesia, sedative; CNS depression, P450 inducer, contraindicated in patients with porphyrias Pharmacology Neurology
|
|
Triazolam
|
oxazepam, midazolam (mechanism, use, toxicity),Short-acting benzodiazepines; more addictive potential Pharmacology Neurology
|
|
Barbituates vs. benzodiazepines (mechanism)
|
Increase duration vs. increase frequency Pharmacology Neurology
|
|
Zolpidem
|
zaleplon, eszopiclone (mechanism, use, toxicity),BZ1 subtype GABA channel agonists; used to treat insomnia Pharmacology Neurology
|
|
Ketamine (mechanism
|
use, toxicity),Blocks NMDA receptor; used as an anesthetic; increases cardiac activity, hallucinations, bad dreams Pharmacology Neurology
|
|
Order of sensory loss when using local anesthetics
|
Pain -> temperature -> touch -> pressure Pharmacology Neurology
|
|
Succinylcholine (mechanism
|
use, toxicity),ACh receptor agonist, produces sustained depolarization and desensitization; used as a paralytic; hypercalcemia, hyperkalemia, malignant hyperthermia Pharmacology Neurology
|
|
Tubocurarine
|
-curium drugs (mechanism, use, toxicity),ACh antagonists; used as paralytics Pharmacology Neurology
|
|
Dantrolene (mechanism
|
use, toxicity),Inhibits release of Ca from sarcoplasmic reticulum and skeletal muscle; used to treat malignant hyperthermia and neuroleptic-malignant syndrome Pharmacology Neurology
|
|
Levodopa/carbidopa (mechanism
|
use, toxicity),Converted to dopamine by dopa decarboxylase in CNS/inhibits peripheral dopa decarboxylase activity; used to treat parkinson symptoms; can cause arrhythmias and "on/off" phenomenon Pharmacology Neurology
|
|
Selegiline (mechanism
|
use, toxicity),MAO-B (prefers dopamine for breakdown) inhibitor, inhibits dopamine breakdown; used to treat parkinson symptoms; enhances adverse effects of levodopa Pharmacology Neurology
|
|
Donepezil
|
galantamine, rivastigmine (mechanism, use, toxicity),ACh esterase inhibitors; used to treat Alzheimer's disease; cholinergic symptoms Pharmacology Neurology
|
|
Sumatriptan (mechanism
|
use, toxicity),Agonist at 1B/1D serotonin receptors; used to treat acute migraines and cluster headaches; coronary vasospasm Pharmacology Neurology
|
|
Trifluoperzine
|
fluphenazine, haloperidol (mechanism, use, toxicity),High potency antipsychotics that antagonize D2 receptors; used to treat schizoprehnia, psychosis, mania, and Tourette's; hyperprolactinemia, anti-cholinergic symptoms (dry mouth, constipation), extrapyramidal effects (dyskinesia), neuroleptic malignany syndrome, tardive dyskinesia (haloperidol) Pharmacology Psychiatry
|
|
Chlorpromazine
|
thioridazine (mechanism, use, toxicity),Low potency antipsychotics that antagonize D2 receptors; used to treat schizophrenia, psychosis, mania, and Tourette's; corneal deposits (chlorpromazine), retinal desporits (thioridazine) Pharmacology Psychiatry
|
|
Olanzapine
|
clozapine, quetiapine, risperidone, aripripazole, ziprasidone (mechanism, use, toxicity),Atypical antipsychotics with unknown mechnism; used for schizophrenia, bipolar disorder, OCD, and others; weight gain (olanzapine, clozapine), agranulocytosis (clozapine), seizures (clozapine), prolonged QT (ziprasidone) Pharmacology Psychiatry
|
|
Lithium (mechanism
|
use, toxicity),Unknown mechanism; used for bipolar disorder and SIADH; tremor, sedation, edema, hypothyroidism, polyuria Pharmacology Psychiatry
|
|
Buspirone (mechanism
|
use, toxicity),Agonizes 1A serotonin receptors; used for generalized anxiety disorder; no side effects, but takes 1-2 weeks for improvement Pharmacology Psychiatry
|
|
Fluoxetine
|
paroxetine, sertraline, citalopram (mechanism, use, toxicity),Block reuptake of serotonin from the synaptic cleft; depression and others; sexual dysfunction, sertonin syndrome (hyperthermia, myoclonus, flushing, diarrhea, seizures) Pharmacology Psychiatry
|
|
Venlafaxine
|
duloxetine (mechanism, use, toxicity),Block reuptake of NE and serotonin from synaptic cleft; depression, diabetic neuropathy (duloxetine); hypertension Pharmacology Psychiatry
|
|
-iptyline
|
-ipramine, doxepin, amoxapine (mechanism, use, toxicity),TCAs, block reuptake of NE and serotonin; depression, bewetting (imipramine), OCD (clomipramine); convulsions, coma, arrhythmias, sedation, hypotension, anti-cholinergic effects Pharmacology Psychiatry
|
|
Tranylcypromine
|
phenelzine, isocarboxazid, selegiline (mechanism, use, toxicity),Inhibit breakdown of NE, serotonin, and dopamine; used for atypical depression, anxiety, and hypochondriasis; hypertensive crisis (tyramine in wine/cheese), don't use with other serotonin agonists Pharmacology Psychiatry
|
|
Bupropion (mechanism
|
use, toxicity),Increases NE and dopamine; used for smoking sensation, depression; seizures Pharmacology Psychiatry
|
|
Mirtazapine (mechanism
|
use, toxicity),Alpha-2 antagonist, increases NE and serotonin release, and serotonin receptor agonist; used for depression; sedation, increased appetite with weight gain; Pharmacology Psychiatry
|
|
Maprotiline (mechanism
|
use, toxicity),Blocks NE reuptake; used for depression; sedation, hypotension Pharmacology Psychiatry
|
|
Trazodone (mechanism
|
use, toxicity),Inhibits serotonin uptake; used for insomnia; pripism Pharmacology Psychiatry
|
|
Mannitol (mechanism
|
use, toxicity),Osmotic diuretic; used to treat drug overdose and increased ICP; pulmonary edema, CHF Pharmacology Renal
|
|
Acetazolamide (mechanism
|
use, toxicity),Carbonic anhydrase inhibitor; used for glaucoma, metabolic alklalosis; hyperchloremic metabolic acidosis, ammonia toxicity, sulfa allergy Pharmacology Renal
|
|
Furosemide (mechanism
|
use, toxicity),Inhibits NKCC channel, preventing urine concentration; used in hypertension, CHF, hypercalcemia; ototoxicity, hypokalemia, hypocalcemia, nephritis, gout, sulfa allergy Pharmacology Renal
|
|
Ethacrynic acid (mechanism
|
use, toxicity),Inhibits NKCC channel; used in patients with furosemide (sulfa) allergy; hyperuricemia Pharmacology Renal
|
|
Hydrochlorothiazide (mechanism
|
use, toxicity),Inhibits NaCl reabsorption in DCT and increases Ca reabsorption; hypertension and hypercalcinuria; hyperglycemia, hyperlipidemia, hyperuricemia, hypercalcemia, sulfa allergy Pharmacology Renal
|
|
Spironolactone
|
eplerenone (mechanism, use, toxicity),Aldosterone receptor antagonists; hyperaldosteronism, CHF, hypokalemia; hyperkalemia (arrhythmias), antiandrogen effects with spironolactone Pharmacology Renal
|
|
Triamterene
|
amiloride (mechanism, use, toxicity),Block sodium channels in cortical collecting duct; hyperaldosteronism, CHF Pharmacology Renal
|
|
Captopril
|
enalapril, lisinopril (mechanism, use, toxicity),ACE inhibitor, leads to reduced angiotensin II levels and decreases GFR; prevents heart remodeling, hypertension, CHF; cough, angioedema, transient creatinine increase, hyperkalemia Pharmacology Renal
|
|
Losartan
|
valsartan (mechanism, use, toxicity),Angiotensin II receptor antagonists; similar to ACE inhibitors, but do not cause cough due to normal metabolism of bradykinin Pharmacology Renal
|
|
Leuprolide (mechanism
|
use, toxicity),GnRH analog that acts as an agonist in pulsatile doses and an antagonist in continuous doses; used as an agonist for infertility and an antagonist for prostate cancer, fibroids, and precocious puberty; antiandrogenic Pharmacology Reproductive
|
|
Finasteride (mechanism
|
use, toxicity),5-alpha reductase inhibitor; used for BPH and male-pattern baldness Pharmacology Reproductive
|
|
Flutamide (mechanism
|
use, toxicity),Testosterone receptor antagonist; used in prostate cancer Pharmacology Reproductive
|
|
Ketoconazole (mechanism
|
use, toxicity),Inhibits 17,20-desmolase, stopping sex steroid synthesis; used to treat polycystic ovarian syndrome Pharmacology Reproductive
|
|
Clomiphene (mechanism
|
use, toxicity),Partial estrogen agonist in the hypothalamus, increases release of LH and FSH, stimulating ovulation; used for infertility and PCOS Pharmacology Reproductive
|
|
Tamoxifen (mechanism
|
use, toxicity),Estrogen receptor antagonist at the breast; used for breast cancer; partial agonist at the uterus, can cause endometrial hyperplasia Pharmacology Reproductive
|
|
Raloxifene (mechanism
|
use, toxicity),Estrogen receptor agonist at bone, inhibits osteoclast activity and stimulates osteoblast activity; used to treat osteoporosis Pharmacology Reproductive
|
|
Anastrozole
|
exemestane (mechanism, use, toxicity),Aromatase inhibitors; used in breast cancer Pharmacology Reproductive
|
|
Mifepristone (mechanism
|
use, toxicity),Progesterone receptor antagonist, given with misoprostol for abortion; abortifacient; bleeding, abdominal pain Pharmacology Reproductive
|
|
Terbutaline (mechanism
|
use, toxicity),Beta-2 agonist, inhibits uterine contractions Pharmacology Reproductive
|
|
Tamsulosin (mechanism
|
use, toxicity),Alpha-1 antagonist; used to treat BPH Pharmacology Reproductive
|
|
Sildenafil
|
vardenafil (mechanism, use, toxicity),Phosphodiesterase 5 inhibitors, causing inc. cGMP levels and smooth muscle relaxation; used in erectile dysfunction; impaired blue-green vision, contradindicated with nitrates Pharmacology Reproductive
|
|
Danazol (mechanism
|
use, toxicity),Partial androgen receptor agonist; used to treat endometriosis and hereditary angioedema; weight gain, acne, hirsutism, low HDL, hepatoxicity Pharmacology Reproductive
|
|
Treat methemoglobinemia with
|
Methylene blue Pharmacology Respiratory
|
|
Diphenhydramine
|
dimenhydrinate, chlorpheniramine (mechanism, use, toxicity),(First generation) H1 antagonists; used in allergies, motion sickness, insomnia; sedation, antiadrenergic, antiserotonergic, and antimuscarinic effects due to CNS penetration Pharmacology Respiratory
|
|
Loratadine
|
fexofenadine, desloratadine, cetrizine (mechanism, use, toxicity),H1 antagonists; used in allergies; less fatigue than other antihistamines due to decreased CNS penetration Pharmacology Respiratory
|
|
Albuterol (mechanism
|
use, toxicity),Short-acting beta-2 agonist; asthma Pharmacology Respiratory
|
|
Salmeterol
|
formoterol (mechanism, use, toxicity),Long-acting beta-2 agonist; asthma; tremor, arrhythmias Pharmacology Respiratory
|
|
Theophylline (mechanism
|
use, toxicity),Phosphodiesterase inhibitor, increases cAMP and causes bronchodilation; asthma; cardiotoxicity, neurotoxicity Pharmacology Respiratory
|
|
Ipratropium (mechanism
|
use, toxicity),Muscarinic antagonist, prevents bronchoconstriction; asthma and COPD Pharmacology Respiratory
|
|
Beclomethasone
|
fluticasone (mechanism, use, toxicity),Inhibit cytokine synthesis, reducing inflammation due to asthma Pharmacology Respiratory
|
|
Montelukast
|
zafirlukast (mechanism, use, toxicity),Leukotriene receptor antagonists; especially useful in aspirin-induced asthma Pharmacology Respiratory
|
|
Zileuton (mechanism
|
use, toxicity),Inhibits activity of 5-lipoxygenase, inhibiting leukotriene production; reduces inflammation Pharmacology Respiratory
|
|
Omalizumab (mechanism
|
use, toxicity),Anti-IgE antibody; used in refractory allergic asthma Pharmacology Respiratory
|
|
Guaifenesin (mechanism
|
use, toxicity),Thins respiratory secretions Pharmacology Respiratory
|
|
N-acetylcysteine (mechanism
|
use, toxicity),Loosens mucus plugs; used in CF patients and as an antidote to acetominaphen posioning Pharmacology Respiratory
|
|
Bosentan (mechanism
|
use, toxicity),Antagonizes endothelin-1 receptors, reducing vascular resistance in the pulmonary vessels; used in pulmonary hypertension Pharmacology Respiratory
|
|
Dextromethorphan (mechanism
|
use, toxicity),Antagonizes NMDA receptors, inhibiting coughing; produces opioid effects in large doses and carries mild abuse potential Pharmacology Respiratory
|
|
Pseudoephedrine
|
phenylephrine (mechanism, use, toxicity),Alpha-1 agonists that reduce edema and nasal congestion; rhinitis; hypertension, quick tolerance (recurrence of symptoms despite continued treatment) Pharmacology Respiratory
|
|
Difference in competitive vs noncompetitve inhibitors?
|
competitive = decrease potency, noncompetitive = decrease efficacy. Pharmacology General
|
|
What is Km?
|
Inverse relation of affinity of enzyme for its substrate. Pharmacology General
|
|
What is Vmax?
|
Direct proportion to enzyme concentration Pharmacology General
|
|
What is bioavailability?
|
Fraction of administered drug that reaches systemic circulation unchanged. Pharmacology General
|
|
Time to steady state depends on?
|
depends on half-life. Does not depend on frequency or size of dose. Pharmacology General
|
|
What is rate of elimination in zero order kinetics?
|
constant amount eliminated per time. Pharmacology General
|
|
Give three drugs that are zero order eliminated.
|
PEA - phenytoin, Ethanol, Aspirin. Pharmacology General
|
|
What is the rate of elimination for first order kinetics?
|
A constant FRACTION is eliminted, variable by concentration! Pharmacology General
|
|
How does ionization relate to urine pH?
|
Ionzied species are trapped in urine and not resorbed. Neutral can be resorbed. Pharmacology general
|
|
How do you treat overdose of weak acid? Give drug examples.
|
Treat with Bicarb to make neutral. Exp: phenobarbital, methotrexate, aspirin. Pharmacology general
|
|
How do you treat overdose of weak base? Give drug examples.
|
Treat with ammonium chloride. exp: amphetamines. Pharmacology general
|
|
What is phase I drug metabolism? What pt. population loses this?
|
Reduction, Oxidation, hydrolysis with CYP450. Often gives neutral products. Geriatrics lose this phase. Pharmacology general
|
|
What is phase II metaboloism? What population depend on this?
|
Conjugation (Glucuronidation, Acetylation, and Sulfation.) Gives charged products. Geriatrics depend on this, old people have GAS. Pharmacology general
|
|
What is efficacy?
|
maximal effect a drug can produce. Pharmacology general
|
|
What is potency?
|
amount of drug needed for the same effect. Pharmacology general
|
|
What happends to efficacy when a partial agonist and full agonist are mixed?
|
DECREASED efficacy. fight for same binding site, full agonist cant exert full effect. Pharmacology general
|
|
What is therapetuic index?
|
LD50/ED50. Median lethal dose divded by median effective dose. Safer drugs have a higher TI. pharmacology general
|
|
What is a therapeutic window?
|
Minimum effective dose to minimum toxic dose. Think of it as range of use. pharmacology general
|
|
What are the two types of Nicotonic receptors? What kind of messenger do they use?
|
1. Nicotinic - Ligang gated Na/K channels. Two nicotinic types: Nm(NMJ) and Nn(autonomic ganglia. 2. Muscarinic - G-proteins. 5 types, M1-M5. pharmacology general
|
|
Alpha-1 sympathetic receptor (G-protein class
|
major function),q, increase: vasc. smooth muscle contraction, pupillary dilator muscle contraction, intestinal and bladder sphincter contaction. pharmacology autonomics
|
|
Alpha-2 sympathetic receptor(G-protein class
|
major function),i, decrease: sympathetic outflow, insulin release, lipolysis. increase: platlet aggregation. pharmacology autonomics
|
|
Beta-1 sympathetic receptor(G-protein class
|
major function),s, increase: heart rate, contractilty, renin release, lipolysis pharmacology autonomics
|
|
Beta-2 sympathetic receptor(G-protein class
|
major function),s, vasodilation, brochodilation, increase: heart rate, contractility, lipolysis, insulin release, aqueous humor production. decrease: uterine tone, ciliary muscle tone. pharmacology autonomics
|
|
M-1 Parasymp receptor(G-protein class
|
major function),q, CNS, enteric nervouse system. pharmacology autonomics
|
|
M-2 Parasymp(G-protein class
|
major function),i, decease: heart rate, contractility of atria pharmacology autonomics
|
|
M-3 parasymp(G-protein class
|
major function),increase: exocrine gland secretion (tears, gastric, etc), gut peristalsis, bladder contraction, bronchoconstriction, pupillary spinchter contraction, cilliary muscle contraction. pharmacology autonomics
|
|
What receptor is responsible for miosis and accomadation?
|
Parasympathetic M-3. pharmacology autonomics
|
|
What receptor is responsbile for mydriasis?
|
Sympathetic Alpha-1. pharmacology autonomics
|
|
Dopamine D-1 receptor(G-protein class
|
major function),s, relaxes renal vascular smooth muscle pharmacology autonomics
|
|
Dopamine D-2 receptor(G-protein class
|
major function),i, modulates transmitter release especially in brain. pharmacology autonomics
|
|
Histamine H-1 receptor(G-protein class
|
major function),q, increase: mucus production, contraction of bronchioles, pruritus, pain. pharmacology autonomics
|
|
histamine H-2 receptor(G-protein class
|
major function),a, increase gastric acid secretion pharmacology autonomics
|
|
vasopression V-1 receptor(G-protein class
|
major function),q, increase: vascular smooth muscle contraction pharmacology autonomics
|
|
vasopression V-2 receptor(G-protein class
|
major function),s, increase water permeability and reabsorption in kidneys. (V2 found in 2 kidneys). pharmacology autonomics
|
|
Which receptors work via Gq -> Phospholipase C ->Pip2->DAG + IP3?
|
H1,Alpha1,V1,M1,M3. (remember HAVe 1 M&M) pharmacology autonomics
|
|
DAG causes activation of what?
|
Protein Kinase C. pharmacology autonomics
|
|
IP3 causes increase in what?
|
Calcium -> smouth muscle contraction pharmacology autonomics
|
|
Which receptors work via Gi->Adenyly cyclase ->cAMP ->Protein Kinase A?
|
M2, Alpha2, D2. (remember MAD 2's.) pharmacology autonomics
|
|
Which receptors work via Gs->adenylyate cyclase ->cAMP->Protein Kinase A?
|
Beta1, Beta2, D1, H2,V2. pharmacology autonomics
|
|
What does protein kinase A do?
|
increase calcium release in heart and blocks myosin light chain kinase. pharmacology autonomics
|
|
What are the two classes of cholinomimetics?
|
1. direct agonsts 2. indirect agonists (anticholinesterases). pharmacology autonomics
|
|
Bethanechol(mechanism
|
use,toxicity),Direct cholinomimetic. Postop or neurogenic ileus, urinary retention. COPD+asthma exacerbation, peptic ulcers. pharmacology autonomics
|
|
Carbachol(mechanism
|
use,toxicity),Direct Cholinomimetic. Identical to Ach. Glaucoma, pupillary contraction, relief of IOP. COPD+asthma exacerbation, peptic ulcers. pharmacology autonomics
|
|
Pilocarpine(mechanism
|
use,toxicity),Direct Cholinomimetic. Stimulates tears, salvia, sweat. Open and closed-angle glaucoma.COPD+asthma exacerbation, peptic ulcers. pharmacology autonomics
|
|
methacholine(mechanism
|
use,toxicity),Direct Cholinomimetic. challenge test of asthma diagnosis. COPD+asthma exacerbation, peptic ulcers. pharmacology autonomics
|
|
Neostigmine(mechanism
|
use,toxicity),Indirect cholinomimetic agonist. NO cns penetration. Postop and neurogenic ileus, myasthenia gravis, reversal of NMJ block. COPD+asthma exacerbation, peptic ulcers. pharmacology autonomics
|
|
pyridostigmine(mechanism
|
use,toxicity),indirect cholinomimetic agonist. Long acting myasthenia gravis treatment. COPD+asthma exacerbation, peptic ulcers. pharmacology autonomics
|
|
edrophonium(mechanism
|
use,toxicity),indirect cholinomimetic agonist. Short acting, for myasthenia gravis diagnosis. COPD+asthma exacerbation, peptic ulcers. pharmacology autonomics
|
|
Physostigmine(mechanism
|
use,toxicity),indirect cholinomimetic agonist. for anti-cholinergic overdose, crosses BBB. COPD+asthma exacerbation, peptic ulcers. pharmacology autonomics
|
|
Donepezil(mechanism
|
use,toxicity),indirect cholinomimetic agonist. Alzheimers disease. COPD+asthma exacerbation, peptic ulcers. pharmacology autonomics
|
|
signs of cholinesterase inhibitor poisoning. treatment.
|
DUMBBELSS (diarrhea, urination, miosis, bronchospasm, bradycardia, excitation of skeletal muscle +CNS, lacrimation, sweating, salvia.) tx: atropine + pralidoxime. pharmacology autonomics
|
|
Parathion(mechanism
|
treatment),Irreversible cholinesterase inhibitor, ACH overdose. Tx: atropine + pralidoxime. pharmacology autonomics
|
|
Atropine
|
homatropine, tropicamide (mechanism, use, toxicity).,Muscarinic antagonist. produces mydriasis and cycloplegia. (Atropine also used for bradycardia). Causes hot as a hare, dry as bone, red as beet, blind as bat, mad as a hatter. pharmacology autonomics
|
|
Benztropine(mechanism
|
use,toxicity),Muscarinic antagoist. Parkinsons disease (park my benz). Causes hot as a hare, dry as bone, red as a beet, blind as a bat, mad as a hatter. pharmacology autonomics
|
|
Scopolamine(mechanism
|
use,toxicity),Muscarinic antagonist. Motion sickness. causes hot as a hare, dry as a cone, red as a beet, blind as a bat, mad as a hatter. pharmacology autonomics
|
|
Ipratropium
|
tiotropium (mechanism, use, toxicity),Muscarinic antagonist. COPD, Asthma. Causes hot as a hare, dry as a bone, red as a beet, blind as a bat, mad as a hatter. pharmacology autonomics
|
|
Oxybutynin(mechanism
|
use,toxicity),Muscarinic anatagonist. reduces urgency in mild cystitis and reduce bladder spasms. causes hot as a hare, dry as a bone, red as a beet, blind as a bat, mad as a hatter.
|
|
Glycopyrrolate(mechanism
|
use,toxicity),Muscarinic anatagonist. IP: given in preop to reduce airway secretions. oral:reduce drooling, peptic ulcer. Can cause hot as a hare, dry as a bone red as a beet, blind as a bat, mad as a hatter. pharmacology autonomics
|
|
Jimson Weed(mechanism
|
toxicity),muscarinic antagonist, causes gardner's pupil (mydriasis). pharmacology autonomics
|
|
Epinephrine(Mechanism
|
receptors bound, use, toxicity),Direct Sympathomemetic. A1,A2,B1,B2. Anaphylaxis, open angle glaucoma, asthma, hypotension. pharmacology autonomics
|
|
Norepinephine(Mechanism
|
receptors bound, use, toxicity),direct sympathomemetic. A1,A2, some B1. used in hypotension but it decrease renal perfusion. pharmacology autonomics
|
|
Isoproterenol(Mechanism
|
receptors bound, use, toxicity),Direct sympathomemetic. B1, B2. Used in Torsade de pointe and bradyarryhmia. Can cause tachycardia and worsen cardiac ischemia. pharmacology autonomics
|
|
dopamine(Mechanism
|
receptors bound, use, toxicity),Direct sympathomimetics. Receptors depend on dose. low = D1, med = D1,B2,B1, high = A1,A2,B1,B2,D1. Used in shock and heart failure (ionotropic and chronotropic). pharmacology autonomics
|
|
dobutamine(Mechanism
|
receptors bound, use, toxicity),Direct sympathomimetic. Mostly B1, little a1,a2,b2. Used in heart failure and cardiac stresstest (ionotrpic and chronotropic) pharmacology autonomics
|
|
Phenylephrine(Mechanism
|
receptors bound, use, toxicity),Direct sympathomimetic. A1, A2. Used in hypotension, to cause mydriasis, and rhinitis (decongestant). pharmacology autonomics
|
|
Albuterol
|
salmetrol, terbutaline (Mechanism, receptors bound, use, toxicity),Direct sympathomimetic. Mostly B2, some b1. Sal = long term ashtma or copd. Albuterol for short term asthma. Terbutaline for to reduce premture uterine contractions. pharmacology autonomics
|
|
Ritodrine(Mechanism
|
receptors bound, use, toxicity),Direct sympathomimetic. B2 only. Used to reduce premature uterine contractions. pharmacology autonomics
|
|
Amphetamine (mechanism
|
use),indirect sympathomimetic. Releases stored catecholamines. Used for narcolepsy, obesity, ADD. pharmacology autonomics
|
|
Epinephrine(Mechanism
|
use, toxicity),indirect sympathomimetic. Releases stored catecholamines. Used for nasal decongestion, urinary incontience, hypotension. pharmacology autonomics
|
|
Cocaine (mechanims
|
use).,direct sympathomimetic. Reuptake inhibitor. Causes vasoconstriction and local anesthesia. pharmacology autonomics
|
|
Why must B-Blockers be avoided in suspected cocaine intoxication?
|
mixing them can lead to unopposed A1 activation and extreme hypertenion. pharmacology autonomics
|
|
How does norepinephrine cause reflex bradycardia?
|
stimulates A1>B2. Causes increased vasoconstrciton -> increased BP. This causes reflex bradycardia and slowing of HR. pharmacology autonomics
|
|
How does isoproterenol cause reflex tachycardia?
|
Stimulates B2>A1. This cause vasodilation and dropping of BP. B1 is stimulated and causes tachycardia. pharmacology autonomics
|
|
Clonidine
|
alpha-methyldopa(Mechanism, receptors bound, use),Centrally acting alpha-2 agonists, this causes LESS peripheral sympathetic release.Used in hypertension, especially renal disease due to no increase in renal blood flow! pharmacology autonomics
|
|
Phenoxybenzamine(Mechanism
|
receptors bound, use, toxicity),IRREVERSIBLE nonslective alpha blocker. Used in pheochromosytoma BEFORE surgery! toxic: orhtostatic hypotension, reflec tachycardia. pharmacology autonomics
|
|
phentolamine(Mechanism
|
receptors bound, use, toxicity),REVERSBILE nonselective alpha blocker. give to patients on MAOI who each tyramine contraining foods. pharmacology autonomics
|
|
Prazosin
|
Terazosin, Doxazosin,Tamsulosin(Mechanism, receptors bound, use, toxicity),Alpha-1 blocker. Used in hypertension, urinary rentention in BPH. tox:orthostatic hypotension, dizziness, headache. pharmacology autonomics
|
|
Mirtazapine (mechanism
|
use, toxicity),Alpha-2 blocker. Used in depression. tox: sedation, hypercholesterolemia, increased apetite. pharmacology autonomics
|
|
Describe what occurs when you alpha-blockade epi vs. phenylephrine.
|
Before blockade: Both epi and phen RAISES BP. After alpha blockade: only epi raises, no change in phenyl. Why: Epi has B binding, phenyl does NOT. pharmacology autonomics
|
|
Give 6 applications of Beta-blockers in general.
|
Angina - decreases HR and contractility, decreasing oxygen use. MI - decrease mortality. SVT - decrease AV duction. Hypertension - decrease CO and renin secretion. CHF - slows progression. Glaucoma - decrease secretion of aqueous humor. pharmacology autonomics
|
|
give general toxicites of b-blockers
|
impotence, asthma exacerbation, bradycardia, seizures, sedation, hides hypoglycemia. pharmacology autonomics
|
|
What are the B1 selective b-blockers? When are they useful?
|
A BEAM. acebutolol, betaxolol, Esmolol, Atenolol, Metoprolol. Useful in comorbid pum. disease. pharmacology autonomics
|
|
What are the nonselective ( b1 = b2) b-blockers?
|
Please Try Not Being Picky. Propranolol, Timolol, Nadolol, Pindolol. B = B-blocker. pharmacology autonomics
|
|
what are the nonselective a and b-antagonists?
|
Carvedilol, labetalol. pharmacology autonomics
|
|
What are the partial B-agonists?
|
Pindolol, Acebutolol. pharmacology autonomics
|
|
Give treatment for acetaminophen overdose.
|
N-Acetylcysteine (replenishes glutathione). pharmacology overdose
|
|
Give treatment for salicylates overdose.
|
NaHCO3 (alkalinize urine) pharmacology overdose
|
|
give treatment for amphetamines overdose
|
NH4Cl (acidify urine) pharmacology overdose
|
|
Give treatment for antimuscarinic and anticholinergic overdose.
|
Phygostigmine and control the hyperhermia. pharmacology overdose
|
|
Give treatment for b-blocker overdose
|
Glucagon pharmacology overdose
|
|
Give treatment for digitalis overdose
|
(KLAM) normalize K, Lidocaine, Anti-dig fab fragments, Mg2 pharmacology overdose
|
|
give treatment for iron overdose.
|
deFEroxamine, deFErasirox. pharmacology overdose
|
|
give treatment for lead overdose
|
CaEDTA, dimercaprol, succimer, penicillamine pharmacology overdose
|
|
give treatment for mercury
|
arsenix, gold overdose,Dimercaprol, succiner pharmacology overdose
|
|
give treatment for copper
|
arsenic, gold overdose,penillamine pharmacology overdose
|
|
give treatment for cyanide
|
nitrite + thiosulfate, hydroxocobalamin pharmacology overdose
|
|
give methemoglobin treatment
|
Methylene blue, vitamin c pharmacology overdose
|
|
Give Carbon monocide treatment
|
100% oxygen or hyperbaric oxygen pharmacology overdose
|
|
give treatment for methanol
|
ethylene glycol overdose,Fomepizole>Ethanol, dialysis pharmacology overdose
|
|
give treatment for opiods overdose
|
naloxone/naltrexone pharmacology overdose
|
|
give treatment for benzodiazepine overdose
|
flumazenil pharmacology overdose
|
|
give treatment for TCA overdose
|
NaHCO3 (alkalinize plasma) pharmacology overdose
|
|
give treatment for heparin overdose
|
protamine pharmacology overdose
|
|
give treatment for warfarin overdose
|
Vitamin K, fresh frozen plasma pharmacology overdose
|
|
give treatment for tPA
|
Streptokinase, urokinase overdose,aminocaproic acid pharmacology overdose
|
|
give treatment for theophylline overdose
|
B-Blockers pharmacology overdose
|
|
give treatment for acetylcholinesterase inhibitors
|
atropine + pralidoxime pharmacology overdose
|
|
causes coronary vasospam
|
cocaine, sumatriptan, ergots pharmacology reactions
|
|
causes cutaneous flushing
|
(VANC) Vancomycin, Adenosine, Niacin, Ca blocker pharmacology reactions
|
|
causes dilated cardiomyopathy
|
doxorubicin, daunorubicin pharmacology reactions
|
|
causes torsades de pointes
|
class III (sotalol) and class Ia (quinidine) pharmacology reactions
|
|
causes agranulocytoisis
|
Clozapine, Carbamazepine, Colchine, Propylthiouracil, Methimazole, Dapsone pharmacology reactions
|
|
causes aplastic anemia
|
chloramphenicol, benzene, NSAIDs, propylthiouracil, methimazole pharmacology reactions
|
|
causes direct coombs positive hemolytic anemia
|
methyldopa, penicillin pharmacology reactions
|
|
causes gray baby syndomr
|
chloramphenicol pharmacology reactions
|
|
causes hemolysis in G6PD-defiect patients
|
(hemolysis IS PAIN)isoniazid, sulfonamides, primaquine, aspirin, ibuprofen, nitrofurantoin pharmacology reactions
|
|
causes megaloblastic anemia
|
(females with PMS are on full BLAST mode) Phenytoin, Methotrexate, Sulfa drugs pharmacology reactions
|
|
Causes thrombotic complications
|
OCPs like estrogen pharmacology reactions
|
|
Causes cough
|
ACE inhibitors pharmacology reactions
|
|
causes pulmonary fibrosis
|
Bleomycin, amiodarone, Busulfan pharmacology reactions
|
|
causes acute cholestatic hepatits
|
jaundice,erthryomycin pharmacology reactions
|
|
causes focal to massice hepatic necrosis
|
Halothane, Amanita Phalloides, Valrpoic acid, Acetaminophen pharmacology reactions
|
|
causes hepatits
|
isoniazid pharmacology reactions
|
|
can lead to pseudomembranous colitis
|
clindamycin, ampicillin pharmacology reactions
|
|
can lead to adrenocortical insufficiency
|
glucocorticoid withdrawl via HPA suppression pharmacology reactions
|
|
can causes gynecomastia
|
`(Some drugs create awkward knockers) spironolactone, digitalis, cimetidine, chronic alcohol use, ketoconazole pharmacology reactions
|
|
causes hot flashes
|
estrogen, clomophene pharmacology reactions
|
|
causes hypergylcemia
|
niacin, tacrolimus, protease inhibitor, HCTZ, corticosteriods pharmacology reactions
|
|
causes hypothyroidism
|
lithium, amiodarone, suldonamides pharmacology reactions
|
|
causes fat redistribution
|
glucocoricoids, protease inhibitors pharmacology reactions
|
|
causes gingival hyperplasia
|
phenytoin, verpamil pharmacology reactions
|
|
causes gout
|
furosemide, thiazides, niacin, cyclosporine pharmacology reactions
|
|
causes myopathies
|
fibrates, niacin, colchine, hydroxychloroquine, interferon-alpha, penicillamine, statins, glucocorticoids pharmacology reactions
|
|
causes osteoporosis
|
corticosteroids, heparin pharmacology reactions
|
|
causes photosensitivty
|
(SAT for a PHOTO) Sulfonamides, amiodarone, tetracycline pharmacology reactions
|
|
causes rash/SJS
|
penicillin, ethosuximide, carbamazepine, sulfa drugs, lamotrigine, allopurinol, phenytoin, phenobarbital pharmacology reactions
|
|
cause drug induced lupus
|
Hydralazine, isonizid, procainamine, phenytoin pharmacology reactions
|
|
causes teeth problems
|
tetracyclines pharmacology reactions
|
|
causes tendonitis
|
tendon rupture, tooth damage,fluoroquinolones pharmacology reactions
|
|
causes diabetes insipidus
|
lithium, demeclocycline pharmacology reactions
|
|
causes fanconi's syndome
|
expired tetracycline pharmacology reactions
|
|
causes hemorrhagic cystits
|
Cyclophosamide, ifosfamide pharmacology reactions
|
|
causes interstital nephritis
|
methicllin, NSAID, furosemide pharmacology reactions
|
|
causes SIADH
|
carbamazepine, cyclophosamide pharmacology reactions
|
|
causes cinchonism
|
Quinidine, qunine pharmacology reactions
|
|
causes parkinson-like syndome
|
antipsychotics, resperine, metoclopramide pharmacology reactions
|
|
causes seizures
|
(with seizures, I BITE My tongue) isoniazid, Buproprion, imipenem, Tramadol, Enflurane, Metoclopramide pharmacology reactions
|
|
causes tardive dyskinesia
|
antipsychotics pharmacology reactions
|
|
acts like an anti-muscarinic
|
Atropine, TCA, H1-blocker, neuoleptics pharmacology reactions
|
|
can cause a disulfiram like reaction
|
metronidazole, some cephalosporins, procarbazine, 1st gen sulphonoureas pharmacology reactions
|
|
can cause nephro/ototoxicity
|
aminoglycosides, vancomycin, loop dieuetics, cisplatin pharmacology reactions
|
|
list p450 inducers
|
(Momma Barb Steals Phen-phen and Refuses Greasy Carbs Chronically)Modafinil, Barbiturates, St. John wart, phenytoin, rifampin, griseofulvin, carbamazepine, chronic alcohol use. pharmacology reactions
|
|
list p450 inhibitors
|
(MAGIC ROCKS in GQ) Macrolides, amiodarone, grapefruit juice, isoniazid, cimetidine, ritonavir actue alcohol use, ciprofloxacin, ketoconazole, sulfonamides, gemfibrozil, quinidine. pharmacology reactions
|
|
lists the sulfa drugs
|
(Popular FACTSSS) probenacid, furosemide, acetazolamide, celecoxib, thiazide, sulfonamide antibiotics, sulfaasalazine, sulfonylureas pharmacology reactions
|
|
Difference between peniciliin G and V.
|
G = IV and IM. V = oral. pharmacology micro
|
|
Penicillin(mechanism
|
use,toxicity),Bind penicillin-binding proteins(transpeptidases), block cross linking of peptidoglycans;most effective on G+, also N. Meningitidis, Treponema;hypersensitivy reaction, hemolytic anema. pharmacology micro
|
|
Oxacillin
|
Naficillin,Dicloxacillin(mechanism,use,toxicity),bind transpeptidases, penicillanse resistant due to bukly r-group blocking B-Lactamse; S. Aureus, except MRSA; hypersensitivity and interstitial nephritis. pharmacology micro
|
|
Ampicillin
|
amoxicillin(mecanism,use,toxicity),bind transpeptidases, wide spectrum and more penicillinase sensitive. combo with claculanic acid to protect from B-lactams;kills enterococci(HELPSS)H.iB, E.coli,Listera,Proteus,Salmonella,Shigella,enterococci;hypersensitivity reaction,rash,pseudomemrane colitis. pharmacology micro
|
|
Which has better bioavailibility; amoxicllin or ampicillin?
|
amOxicllin has better Oral bioavilability. pharmacology micro
|
|
What does clavulanic acid do?
|
B-lactamse inhibitor pharmacology micro
|
|
Ticarcillin
|
piperacillin(mechanism,use,toxicity),transpeptidase inhibitor but extended spectrum;pseduomonas and g- rods, use with claculanic acid due to B-lactamse suspectibilty; hypersensitivity reaction. pharmacology micro
|
|
List the B-lactamse inhibitors
|
(CAST) Clavulanic Acid, Sulbactam,Tazobactem. pharmacology micro
|
|
Cephalosporin(mechanism
|
use,toxiciity),inhibit cell wall synthesis but are less susceptible to B-lactamases, are bactericidal;use depends on generation, there are four;hypersensitivty reactions, vitamin K defiency, increased nephrotoxicity of aminoglycosides. pharmacology micro
|
|
give use of cefazolin
|
cephalexin.,1st generation cephalosporins. PEcK. Proteus, E.coli,Klebsiella. Cefazolin used preop to prevent A.aureus infections. pharmacology micro
|
|
give use of cefoxitin
|
cefaclor,cefuroxime`,2nd generation cephalosporins. HEN PEcKs. H.ib, Enterbacter, Neisseria, Proteus, E.coli,Klebsiella, Serratia. pharmacology micro
|
|
give use of ceftriaxone
|
cefotaxime,ceftazidime,3rd gen. cephalosporins. Serious gram - infections. Ceftriaxone = meningitis and gonorrhea. Ceftazidime = pseudomonas. pharmacology micro
|
|
give use of cefepime.
|
increased activity against pseudomonas and G+ bugs. pharmacology micro
|
|
Aztreonam(mechanism
|
use,toxicty),a monobactem resistant to B-lactamases, prevents binding to PBP3 and is synergistic with aminoglycosides;gram - rods only;very nontoxic, some GI upset. pharmacology micro
|
|
what transpeptidase inhibitor can be used in penicillin allergy?
|
aztreonam. pharmacology micro
|
|
imipenem/cilastatin
|
meropenem,etrapenem,doripenem(mechanism,use,toxicity),broad spectrum, B-lactamase resistent but imipenem needs cilastatin to inhibit renal dehydropeptidase. later carbepenems do not;G+ cocci,G- rods, anerobes. used only in life threating events;skin rash, CNS toxicity, seizures. pharmacology micro
|
|
Vancomycin(mechanism
|
use,toxicty),inhibits cell wall binding peptidoglycan formation by binding D-ala percursors, is bacterialcidal; G+ only, especially for multidrug resistant onces;NOT - nephrotoxicity, ototoxicity, thrombophlebitis, red man syndrome. pharmacology micro
|
|
How is redman syndrome prevented in vancomycin use?
|
slow infusion and rate and antihistamines. pharmacology micro
|
|
How does vancomycin resistant occur?
|
amino acid change of D-ala D-ala to D-ala D-lac. pharmacology micro
|
|
List antibiotic protein synthesis inhibitors
|
AT 30, CCEL at 50. 30S = Aminoglycosides, Tetracyclines. 50S = Chloramphenicol, Clindamycin, Erythromycin, Linezolid. pharmacology micro
|
|
Gentamicin
|
neomycin, amikacin,tobramycin,streptomycin(mechanism,use,toxicity),aminoglycosides, bacterialcidal, block translocation but require oxygen for uptake;ineffective in anaerobes,use in gram - rod infections and before bowel surgery; nephrotoxicty, NMJ block, ototoxicity, teratogen. pharmacology micro
|
|
how does resistenace to aminoglycosides occur?
|
transferase enzymes that inactivate the drug by acetylation, phosphorylation, or adenylation. pharmacology micro
|
|
tetracycline
|
doxycycline, demecycline,minocycline(mechanism, use, toxicity),bacteriostatic, prevents aminoacyl-tRNA binds;Borrela, M. Pneuomo, Rickettsia, Chlamysia; can't take with milk, antacids, iron because ions bind it, GI distress, discoloration of teeth, inhibition of bone growth, contraindication in pregnancy. pharmacology micro
|
|
how does resistance to tetracyclines occur?
|
decrease uptake into cells or increased efflux by pumps. pharmacology micro
|
|
Azithromycin
|
clarithromycin, erythromycin(mechanism,use,toxicity),bacteriostatic, blocks translocation; atypical pneumonias, chlamydia, gram + cocci; MACRO: increased Motility, arrhythmia, Cholestatic hepatitis, Rash, eOsinophilia. pharmacology micro
|
|
how does resitance to macrolides occur?
|
methylation of 23s rRNA binding site. pharmacology micro
|
|
Chloramphenicol(mechanism
|
use,toxicity),Bacterialstatic, blocks peptidlytransferase; Meningitis in adults, used in power countries due to being cheap; dose dependent anemia, dose independent aplastic anemia, gray baby syndrome. pharmacology micro
|
|
what causes grey baby syndrome?
|
use of chloramphenicol in premature infants, they lack UDO-glucuronyl-transferase. pharmacology micro
|
|
How does resistance to chloramphenicol occur?
|
plasmid-encoded acetyltransferase. pharmacology micro
|
|
clindamycin(mechanism
|
use,toxicity),Bacteriostatic. Blocks peptide transfer; anaerobic infections in lung infections and oral anerobes; C. Diff infection, fever, diarrhea. pharmacology micro
|
|
Sulfamethoxazole(SMX)
|
sulfisoxazole, sulfadiazine(mechanism, use, toxicity),Bacteriostatic, PABA metabolites inhibit dihydropteroate synthase; Gram +, G-, Nocardia, Chlamydia, UTI; hypersensitivty, hemolysis in G6PD, nephrotoxic, kernicterus, displaces other drugs from albumin. pharmacology micro
|
|
how does resistance to sulfonamides occur?
|
altered bacterial dihydropteroate or increased PABA synthesis. pharmacology micro
|
|
Trimethoprim(mechanism
|
use,toxicity),Bacteriostatic, inhibits bacterial dihydrofolate reductase, blocks folate synthesis; used in UTI, PCP (prophylacis and treatment), shigella, salmonella; megaloblastic anemia, leukopenia, granulocytopenia. pharmacology micro
|
|
ciprofloxacin
|
norfloxacin, levofloxacin, etc...(mechanism, use, toxicity),bactericidal, inhibits DNA gyrase(topo II and IV);G- rods of urinary and GI tracts, Neisseria, some G+;( lones hurt the bones) tenonitis and tendon rupture, superinfections, don't give to kids or pregnant women due to cartilage damage. pharmacology micro
|
|
how does resistance to fluroquinolones occur?
|
mutation in DNA gyrase or efflux pumps. pharmacology micro
|
|
What groups are susceptible to fluorquinolone tendon rupture?
|
older than 60 or taking prednisone pharmacology micro
|
|
Metronidazole(mechanism
|
use, toxicity),bacterialcidal, forms free radical toxic metabolites that damge bacterial DNA damage; (GET GAP) Giardia, Entamoeba, trichomonas, Gardnerella, Anaerobes, Pylori; causes disulfiram like reaction, headache, metallic taste. pharmacology micro
|
|
Isoniazid(mechanism
|
use,toxicity),decrease synthesis of mycolic acids, bacterial catalase peroxidase(KatG) must activate INH; TB drug, only one used as prophylaxis and in latent TB; peripheral neuropathy, hepatoxic, lupis like drug interaction, pyridoxine antagonist. pharmacology micro
|
|
Rifampin(mechanism
|
use,toxicity),inhibits DNA-dependent RNA polymerase; TB, Leprosy, prophylaxis in meningococcus and Hib type B; hepatotox, p450 inducer, orange body fluids. pharmacology micro
|
|
Pyrazinamide(mechanism
|
use, toxicity),unknown; TB; hyperuricemia, hepatotoxic. pharmacology micro
|
|
Ethambutol(mechanism
|
use,toxicity),decreased carbohydrate polymerization of TB cell wall, blocks arabinosyltransferase; TB; optic neuropathy(red-green color blindness_ pharmacology micro
|
|
Amphotericin B(mechanism
|
use, toxicity),binds fungal ergosterol, causes holes in membranes; use in systemtic and CNS mycoses infections; fever/chills, hypotension, arrythmias, nephrotoxic, IV phlebitis, must supplement K and MG. pharmacology micro
|
|
nystatin(mechanism
|
use,toxicty),binds fungal ergosterol;topical only due to high toxicity, used for oral thrush and topical diaper rash or vaginal candidiasis. pharmacology micro
|
|
Fluconazole
|
ketoconazole, clotrimazole, itraconazole, voriconazole(mechanism, use,toxicity),inhibits fungal ergosterol synthesis by binding p450;Fluconazole for suppression of cryptococcus in AIDs patients, itraconazle for blasto, coccio, histo. pharmacology micro
|
|
Flucytosine(mechanism
|
use, toxicity),inhibits fungal DNA and RNA synthesis by conversion to 5FU; used in systemic fungal infections, especially cryptococcus; bone marrow suppression. pharmacology micro
|
|
Caspofungin
|
micafungin(mechanism, use, toxicity),inhibits fungal cell wall synthesis by inhibiting B-glucan synthesis; invasive aspergillosis, candida; flushing via histamine releae. pharmacology micro
|
|
terbinafine(mechanism
|
use,toxicity),inhibits fungal squalene epoxidase; treat dermatophytes - toe nail infection especially;abnormal LFT, visual disturbances. pharmacology micro
|
|
Griseofulvin(mechanism
|
use,toxicity),interferes with microtubules, stops mitosis in fungi;deposits in keratin so used in superficial infections, stops dermatophytes; teratogenic, carcinogenic, confusion, p450 inducer. pharmacology micro
|
|
Pyrimethamine use
|
toxoplasmosis pharmacology micro
|
|
suramin and melarsoprol use
|
trypanosoma brucei pharmacology micro
|
|
nifurtimox use
|
trypanosoma cruzi pharmacology micro
|
|
sodium stibogluconate use
|
leshmaniasis pharmacology micro
|
|
Chloroquine(mechanism
|
use,toxicity),blocks formation of heme into hemozoin. Heme accumulates and is toxic to plasmodia;used on all species but falciparum(too much resitance); retinopathy pharmacology micro
|
|
quinidine use
|
lifethreatening malaria pharmacology micro
|
|
artemether/lumifantrine use
|
p. falciparum killing pharmacology micro
|
|
Zanamivir
|
oseltamivir(mechanism,use),inihibits influenza neuraminidase, stops progeny release; treamt of influenze a and b pharmacology micro
|
|
Ribavarin(mechanism
|
use,toxicity),inhibits sythesis of guanine nucleotides by competitvely inhibiting IMP dehydrogenase; RSV, chronic hep C; hemolytic anemia, severe teratogen pharmacology micro
|
|
Acyclovir
|
valacyclovir(mechanism, use, toxicity),Guanosine analog, inhibits viral DNA polymerase; monophosphorylated by thymidine kinase in HSV/VZV so active in lesions and encephalitis, good for prophylaxis, pharmacology micro
|
|
Famciclovir use
|
used in herpes zoster active infections pharmacology micro
|
|
mechanism for resistance to acyclovir
|
mutated viral thymidine kinase pharmacology micro
|
|
Ganciclovir
|
valgangciclovir(mechanism,use,toxicity),guanosine analog, 5'-monophosphate formed by CMV viral kinase, inhibits viral DNA polymerase;CMV infections;leukopenia,neutopenia,thrombocytopenia,renal toxicity pharmacology micro
|
|
mechanism for resistance to acyclovir
|
mutated CMV DNA polymerase or lack of viral kinase pharmacology micro
|
|
Foscarnet(mechanism
|
use,toxicity),viral DNA polymerase inhibitor, binds to pyrofosphate binding site, doesn't need viral kinase activation;CMV retinitis when ganciclovir fails and acyclovir restitant HSV; nephrotoxic pharmacology micro
|
|
mechanism for resistance to foscarnet
|
mutated DNA polymerase pharmacology micro
|
|
cidofovir(mechanism
|
use,toxicity),inhibits DNA polymerase, doesn't require activiation by viral kinase; CMV retenitis, acyclovir resistant HSV; nephrotoxic pharmacology micro
|
|
HAART consist of what?
|
[2 NRTI] +[1 NNRTI OR 1 protease inhibitor OR 1 integrase inhibitor] pharmacology micro
|
|
give mechanism and toxicity of protease inhibitors
|
all end in -NAVIR! stops HIV mRNA cleavage into functional parts; hyperglycemia, GI upset, lipodystrophy. pharmacology micro
|
|
Ritonavir does what to be a "booster"
|
inhibits cytochrome p-450, boosting concentration of other drugs. pharmacology micro
|
|
Tenofovir
|
emtricitabine, abacavir, lamivudine, zidovudine, didansoine, stavudine(mechanism,use,toxicity,(NRTI)competitively blocks binding of nucleotide to reverse transcriptase, only tenofovir doesn't need to be activated;all NRTIs, zidovidine used in pregnancy to reduce fetal transmision; bone marrow suppression, lactic acidosis, peripheral neuropathy. pharmacology micro
|
|
Nevirapine
|
Efavirenz, Delavirdine(mechanism,use,toxicity),(NNRTI) bind at a site different from NRTIs, no don't require activation don't compete with nucleotides; bonow marrow suppression, peripheral neuropathy, lactic acidosis, pharmacology micro
|
|
Raltegravir(mechanism
|
use,toxicity),inhibits integrase, which stops HIV integration into host cells;HIV;hypercholesterolemia pharmacology micro
|
|
Interferons(mechanism
|
use,toxicity),glycoproteins synthesized my virus infected cells, block RNA and DNA virus replication; INFa- chronic hep b and c, Kaposi sarcoma, IFN-b -MS, INF-gamma -NADPH oxidase defiency; neutropenia, myopathy. pharmacology micro
|
|
What antibiotics must be avoided in pregnancy?
|
SAFe Children Take Really Good Care. sulfonamides(kericterus), aminoglycosides(ototox), fluoroquinolones(cartilage damage), Clarithromycin(embryotoxic), Tetracycline(teeth,bone damage),Ribavarin(teratogenic),Griseofulvin(teratogenic),Chloramphenicol(grey baby) pharmacology micro
|
|
benzodiazepines
|
alcohol withdrawl
|
|
ssri
|
anorexia/bulimia
|
|
benzodiazepines
|
buspirone, ssri,anxiety (3)
|
|
methylphenidate
|
amphetamines, atomoxetine,ADHD (3)
|
|
mao inhibitors
|
ssri,atypical depression (2)
|
|
lithium
|
valproic acid, carbamazepine, atypical antipsychotics,bipolar disorder (4)
|
|
ssri
|
snri, tca,depression (3)
|
|
mirtazapine
|
depression with insomnia
|
|
ssri
|
clomipramine,ocd (2)
|
|
ssri
|
tca, benzodiazepines,panic disorder (3)
|
|
SSRI
|
ptsd
|
|
antipsychotics
|
schizophrenia
|
|
antipsychotics (haloperidol)
|
tourette's syndrome
|
|
ssri
|
social phobia
|
|
adhd
|
narcolepsy, appetite control,cns stimulants clinical use
|
|
increased catecholamines at the synaptic cleft (especially NE
|
dopamine),cns stimulants mechanism
|
|
cns stimulant
|
methylphenidate
|
|
cns stimulant
|
dextroamphetamine
|
|
cns stimulant
|
mixed amphetamine salts
|
|
antipsychotic
|
haloperidol
|
|
antipsychotic
|
trifluoperazine
|
|
antipsychotic
|
fluphenazine
|
|
antipsychotic
|
thioridazine
|
|
antipsychotic
|
chlorpromazine
|
|
block dopamine D2 receptors (increases cAMP)
|
typical antipsychotics mechanism
|
|
schizophrenia (positive symptoms)
|
psychosis, acute mania, tourette's syndrome,typical antipsychotics clinical use (4)
|
|
atypical antipsychotic
|
olanzapine
|
|
atypical antipsychotic
|
clozapine
|
|
atypical antipsychotic
|
quetiapine
|
|
atypical antipsychotic
|
risperidone
|
|
atypical antipsychotic
|
aripiprazole
|
|
atypical antipsychotic
|
ziprasidone
|
|
block 5-HT2
|
doapine, alpha, and H1 receptors,mechanism of atypical antipsychotics
|
|
schizophrenia (positive and negative)
|
atypical antipsychotic clinical use
|
|
ocd
|
anxiety disorder, depression, mania, tourette's syndrome,olanzapine clinical use
|
|
mood stabilizer for bipolar disorder
|
blocks relapse and acute manic events, SIADH,lithium clinical use (3)
|
|
not established
|
related to inhibition of phosphoinositol cascade,lithium mechanism
|
|
stimulates 5HT1a receptors
|
buspirone mechanism
|
|
generalized anxiety disorder
|
buspirone clinical use
|
|
increases NE and dopamine via unknown mechanism
|
bupropion mechanism
|
|
smoking cessation
|
antidepressant,bupropion clinical use (2)
|
|
a2 antagonist (increases release of NE and serotonin)
|
antagonist at 5HT2, 5HT3,mirtazapine mechanism
|
|
atypical antidepressant
|
mirtazapine
|
|
atypical antidepressant
|
bupropion
|
|
atypical antidepressant
|
maprotiline
|
|
atypical antidepressant
|
trazodone
|
|
primarily inhibits serotonin reuptake
|
trazodone mechanism
|
|
insomnia (high doses needed for antidepressant effects)
|
trazodone clinical use
|
|
blocks NE reuptake
|
maprotiline mechanism
|
|
block reuptake of NE and serotonin
|
tricyclic antidepressant mechanism
|
|
major depression
|
fibromyalgia,tricyclic antidepressants general use
|
|
bedwetting
|
imipramine special use
|
|
ocd
|
clomipramine special use
|
|
tca
|
imipramine
|
|
tca
|
amitriptyline
|
|
tca
|
desipramine
|
|
tca
|
nortriptyline
|
|
tca
|
clomipramine
|
|
tca
|
doxepin
|
|
tca
|
amoxapine
|
|
ssri
|
fluoxetine
|
|
ssri
|
paroxetine
|
|
ssri
|
sertraline
|
|
ssri
|
citalopram
|
|
serotonin specific reuptake inhibitor
|
mechanism of ssris
|
|
depression
|
ocd, bulimia, social phobias,clinical use of ssris (4)
|
|
cyproheptadine (5HT2 receptor antagonist)
|
treatment of serotonin syndrome
|
|
venlafaxine
|
duloxetine,snris (generic names) 2
|
|
inhibit serotonin and NE reuptake
|
mechanism of SNRIs
|
|
depression
|
generalized anxiety disorder (venlafaxine); diabetic peripheral neuropathy (duloxetine),clinical use of SNRIs (3)
|
|
nonselective MAO inhibition
|
increases levels of (NE, serotonin, dopamine),mao inhibitors mechanism
|
|
atypical depression
|
anxiety, hypochondriasis,mao inhibitors clinical use (3)
|
|
mao inhibitor
|
phenelzine
|
|
mao inhibitor
|
tranylcypromine
|
|
mao inhibitor
|
isocarboxazid
|
|
mao inhibitor (mao-b selective)
|
selegiline
|